Curriculum Vitae

 

 

Ajay Gogia, MD, DM, is an Additional Professor in the Department of Medical Oncology at Dr. B.R.A Institute-Rotary Cancer Hospital All India Institute of Medical Sciences (AIIMS), New Delhi, India. He received his M.B.B.S, MD (Internal Medicine) degree from Banaras Hindu University, DM (Medical Oncology) from AIIMS, New Delhi. He has over 17 year of working and teaching experience in Medical Oncology and specializes in All variants of Breast Cancer, Non-Hodgkin’s Lymphoma,Chronic lymphocytic leukemia, Hodgkin Lymphoma and Multiple Myeloma. He has gained his International exposurein Europe,United states of America (USA), United Kingdom (UK) and Canada throughmultiple fellowships and honoured observerships.. His research is well published with more than 400 peer reviewed articles in National and International oncology journals and is well citedover thousand citations . His letters and correspondence are well accepted and published in reputed journalslike New England journal of Medicine (NEJM), Lancet Oncology, Journal of clinical oncology (JCO) and JAMA Oncology. He has received Dronacharya Award for his excellence by Health Minister ,Thrice Golden aim Award for teaching, patient care and research and best researcher award from Global forum of Artificial Intelligene and Robotics. He is actively involve in management of breast cancer in every aspects :prevention, screening, chemotherapy, hormonal therapy, targeted therapy and immuunotherapy

 

 

Name : Dr. Ajay Gogia

Qualifications : MBBS,

MD (Internal Medicine),

DM (Medical Oncology)

Current Appointment : Additional Professor

Department of Medical Oncology, Dr. B.R.A, I.R.C.H,

All India Institute of Medical Sciences (AIIMS)

Ansari Nagar, New Delhi, 110029

Nationality : Indian

 

Education and Qualifications

Degree	University	Year
MBBS	Institute of Medical Sciences, Banaras Hindu University, Varanasi-India	2000
M.D (Internal Medicine)	Institute of Medical Sciences, Banaras Hindu University, Varanasi-India	2003
D.M. (Medical Oncology)	All India Institute of Medical Sciences(AIIMS),New Delhi, India	2011

  

Working place and post

Post	University/ INSTITUTE	Year
Senior Residency and D.M ( Doctrate of medicine) ( Medical Oncology)	All India Institute of Medical Sciences(AIIMS), New Delhi, India	2006-11
SeniorResearch Associate (Pool Officer)	All India Institute of Medical Sciences(AIIMS), New Delhi, India	2011-12
Assistant Professor	All India Institute of Medical Sciences(AIIMS), New Delhi, India	2013- 2016
Associate Professor	All India Institute of Medical Sciences(AIIMS), New Delhi, India	2017- 2019
Additional Professor	All India Institute of Medical Sciences(AIIMS), New Delhi, India	2020-till date

 

Working&TEACHING experienec in medical oncology:17 years

Specific Area of Interest	OPD Schedule and timing	Member of the multidisciplinary teams of Breast cancer clinic (BCC) and lymphoma clinic at Dr. B.R.A-IRCH, All India Institute of Medical Sciences (AIIMS)and taking care of Medical Management of Breast cancer, B-cell Non Hodgkin lymphoma,Hodgkin Lymphoma, Multiple myeloma andChronic lymphocytic leukemia’s
Breast Cancer	Monday (2.00pm, Breast cancer clinic, Board Room).Wednesday (9.30 am), Adult Medical Oncology clinic, Board Room Friday (9.30 am ) Adult Medical Oncology clinic, Room No 1
Non-Hodgkin and Hodgkin Lymphoma,Chronic lymphocytic leukemia (CLL) and Multiple Myeloma	Thursday (9.30 am, Lymphoma and Myeloma clinic, Room No. 4), Wednesday and Friday (9.30 am, Adult Medical Oncology Clinic, Board Room)

 

Fellowship	PLACE	Year
Indian American cancer Association-(IACA) Fellowship	Cleveland Clinic. OHIO, United States of America (USA) Mentor: Prof. Jame Abraham	2016
European Society Of Medical Oncology (ESMO) Fellowship	Jules Bordet Hospital, Brussels Mentor: Prof. Martine Piccart	2017
MD Anderson Cancer center (MDACC) short term fellowship	MDACC, Houston, Texas,USA Mentor :Prof. Hagop M.Kantarjian / Prof. Jain	2018
ESMO- Palliative care fellowship	Princess Margaret Cancer CentreToronto,Canada Mentor : Prof. Subratha Banerjee	2019

 

Hounoured Observer- ship	PLACE	Year
ESO:Short term in-house observer ship	The Royal Marsden Hospital, London UK	2019
ASH: Short term in-house observer ship	Sarah Cannon Center, Nashville, USA	2017
MASTERCLASS and in house observership on BREAST CANCER	Memorial Sloan Kettering Cancer Center (MSK or MSKCC)	2023

 

Awards/Honors		Year
Dronacharya-Award-Excellence in Oncology	Received by Minister of Health and welfare	2019
Golden Aim Award -Teaching	Received by Minister of Health and welfare	2020
Golden Aim Award -Research	Received by President IMA	2021
Golden Aim Award _Patient care	Received by President IMA	2023
Hans WyderAward	Ascona, Switzerland	2013
Young Investigator Award	International Society of hematology and oncology (SOHO),Texas,USA	2022
Merit Award	Asco2011 ,Chicago,usa	2011
Young Investigator and Best Poster Award	Global Breast Cancer Conference, Seoul	2020
Young Investigator award	Gi-Esmo, Barcelona	2015
Travel scholarship and Best Poster Award	Esmo , Barcelona , Spain	2019
Young investigator award	Saint Gallen Breast Cancer Conference	2013

  

ESMO PRECEPTORSHIP Place Year
Colorectal Cancer	Prague	6-7 July 2016
Immuno-Oncology	Amsterdam,	30 September – 1 October 2015
Signalling Pathways	Barcelona	13 – 14 March 2015
Non-Small Cell Lung Cancer	Copenhagen	7-8 July 2015
GI Neuroendocrine tumors	Singapore	2-3 November 2012

  

International Oncology Research scholarship/grant	PLACE	Year
American Association of Cancer Research (AACR)/Australia & Asia Pacific Clinical Oncology Research Development (ACORD)	Sydney, Australia	2018
INDOX Cancer Research Network	University of Oxford, United Kingdom ( UK)	2012
European Society Of Medical Oncology (ESMO)- Translational unit visit	Christie NHS Foundation Trust, Manchester, United Kingdom ( UK)	2012
European School of Oncology –Master class in clinical Oncology	Ermatingen, Switzerland	2012

Miscellaneous

Principal Investigator: projects -3 ( active ) , total =9

DM ( Medical Oncology ) and DNB Examiner in different hospitalssince 2019

CLINICAL PROJECT – AS A CO- INVESIGATOR with Different super/sub specialties in AIIMS (40 in number)

Setting up Hospital Based Cancer Registries ( HBCRs) and Pattern of Care and Survival Studies on Breast Cancer

DM-Medical Oncology Teaching curriculum & Exam Coordinator: between 2013-2022

Expert member in Executice commetie of Ethics at Safderjang Hospital, New Delhi

Active participation in teaching including MBBS/MD/DM/ MSc Nursing Student

Active Participation in Annual Free Medical Camp organized by AIIMS and Govt. of India at LEH, DHARAMSHALA, Jhanskar,Tawang (Arunachal Pradesh) and MUNGDOD Hubli

Regular Participating in patient awareness programme in DOORDARSHAN, DD news & RAJSABHA TV

 

 CURRENT MEMBERSHIPS IN PROFESSIONAL SOCIETIES

• Members in American Society of Clinical Oncology-(ASCO ID -10476)

• European Society of Medical Oncology- ESMO-ID-(82716)

 

PUBLICATIONS: over 400(Name Highlighted)

• Yadav MP, Ballal S, Martin M, Roesch F, Satapathy S, Moon ES, Tripathi M, Gogia A.Bal C. Therapeutic potential of [¹⁷⁷Lu]Lu-DOTAGA-FAPi dimers in metastatic breast cancer patients with limited treatment options: efficacy and safety assessment. Eur J Nucl Med Mol Imaging. 2024 Feb;5 1(3):805-819. doi: 10.1007/s00259-023-06482-z. Epub 2023 Nov 7. PMID: 37932560.

• Chatzikonstantinou T, Scarfò L, Karakatsoulis G, Minga E, Chamou D, Iacoboni G, Kotaskova J, Demosthenous C, Smolej L, Mulligan S,Alcoceba M, Al-Shemari S, Aurran-Schleinitz T, Bacchiarri F, Bellido M, Bijou F, Calleja A, Medina A, Khan MA, Cassin R, Chatzileontiadou S, Collado R, Christian A, Davis Z, Dimou M, Donaldson D,Santos GD, Dreta B, Efstathopoulou M, El-Ashwah S, Enrico A,Fresa A, Galimberti S, Galitzia A, García-Serra R, Gimeno E, González-Gascón-Y-Marín I, Gozzetti A, Guarente V, Guieze R, Gogia A.et al .Other malignancies in the history of CLL: an international multicenter study conducted by ERIC, the European Research Initiative on CLL, in HARMONY. EClinicalMedicine. 2023 Nov 15; 65:102307.doi: 10.1016/j.eclinm.2023.102307. PMID: 38033506; PMCID: PMC10685149.

• Kumar R, Kumar R, Goel H, Kumar S, Ningombam SS, Haider I, Agrawal U, Deo S, Gogia A.Batra A, Sharma A, Mathur S, Ranjan A, Chopra A, Hussain S, Tanwar P. Whole exome sequencing identifies novel variants of PIK3CA and validation of hotspot mutation by droplet digital PCR in breast cancer among Indian population. Cancer Cell Int. 2023 Oct 11;23(1):236. doi: 10.1186/s12935-023-03075-6. PMID: 37821962; PMCID: PMC10568783.

• Sharma RK, Gogia A.Deo S, Sharma D, Mathur S, Sagiraju HKR. Dose-dense neoadjuvant chemotherapy in triple-negative breast cancer: Real-world data from a developing country. Indian J Cancer. 2023 Oct 1; 60(4):505-511.doi: 10.4103/ijc.ijc_1120_21. Epub 2024 Jan 4. PMID: 38189648.

• Paikaray SK, Gogia A.Kumar L, Sharma A, Biswas AA, Vishnubhatla S, Mallick S. A Phase III open-label randomized study to compare the efficacy of lenalidomide-rituximab with bendamustine-rituximab in treatment-naïve follicular lymphoma. Indian J Cancer. 2023 Oct 1; 60(4):501-504.doi: 10.4103/ijc.IJC_633_20. Epub 2024 Jan 4. PMID: 38185869.

• Kashyap A, Umar SM, Dev J R A, Mathur SR, Gogia A.Batra A, Deo SVS, Prasad CP. Combination of 3PO analog PFK15 and siPFKL efficiently suppresses the migration, colony formation ability, and PFK-1 activity of triple-negative breast cancers by reducing the glycolysis. J Cell Biochem. 2023 Sep;12 4(9):1259-1272. doi: 10.1002/jcb.30443. Epub 2023 Jul 14. PMID: 37450687.

• Sahu MK, Singh SP, Satsangi A, Gogia A.Hote MP, Seth S. Posttransplant lymphoproliferative disorder in a heart transplant recipient:a case report. Indian J Thorac Cardiovasc Surg. 2023 Sep;39(5):535-538. doi: 10.1007/s12055-023-01524-5. Epub 2023 Jun 14. PMID: 37609612; PMCID: PMC10441853

• Gupta A, Gogia A.Deo S, Sharma DN, Mathur S, Sagiraju HKR. Neoadjuvant chemotherapy with or withoutanthracyclines in combination with single HER2-targeted therapy in HER2-positive breast cancer. Cancer Treat Res Commun. 2023;36:100741. doi: 10.1016/j.ctarc.2023.100741. Epub 2023 Jul 9. PMID: 37453371.

• Pandey P, Sharma A, Gogia A.Bone health in breast cancer. Curr Probl Cancer. 2023 Jun;47(3):100959. doi: 10.1016/j.currproblcancer.2023.100959. Epub 2023 May 5. PMID: 37236055.

• Sharma V, Kumar A, Baa A, Kirar S, Sharma A, Bakhshi S, Gogia A.Malik PS, Rastogi S, Batra A, Pushpam D, Kataria B, Sagiraju H, Sharma A, Singh V. Dexamethasone-free antiemetic strategy for highly emetogenic chemotherapy: safety and efficacy-pilot study.BMJ Support Palliat Care. 2023 Mar 16:spcare-2022-003864. doi: 10.1136/spcare-2022-003864. Epub ahead of print. PMID: 36927873.

• Sg N, Gogia A.Sacituzumab Govitecan in Hormone Receptor-Positive Metastatic Breast Cancer. J Clin Oncol.2023 Mar 10;41(8):1631. doi: 10.1200/JCO.22.02113. Epub 2023 Jan 6. PMID: 36608301.

• Mishra A, Oberoi AS, Deo S, Sharma J, Gogia A.Sharma DN, Mathur S, Dhamija E. Bilateral Breast Cancer: Clinical Profile and Management. Indian J Surg Oncol. 2023 Sep;14(3):651-658. doi: 10.1007/s13193-023-01731-x. Epub 2023 Mar 7. PMID: 37900630; PMCID: PMC10611650.

• Jain S, Goswami A, Lone MR, Ramteke P, Gogia A.Aggarwal M, Viswanathan GK, Kakkar D, Mandal T, Sharma A, Sahoo R, Baldia A, Sharma MC, Bakhshi S, Pramanik R, Dhawan R, Kumar L, Mallick S.Follicular Helper T-Cell-derived Nodal Lymphomas: Study of Histomorphologic, Immunophenotypic, Clinical, and RHOA G17V Mutational Profile. Appl Immunohistochem Mol Morphol. 2023 Mar 1;31(3):172-180. doi: 10.1097/PAI.0000000000001105. Epub 2023 Feb 20. PMID: 36806188.

• Taneja N, Dev T, Patel U, Arava S, Gogia A.Gupta V. Rapidly progressive hyperpigmented keratotic plaques with epidermotropism. Indian J Dermatol VenereolLeprol. 2023 Jan-Mar;8 9(2):283-286. doi: 10.25259/IJDVL_1200_20. PMID: 34379962.

• Mansouri L, Thorvaldsdottir B, Sutton LA, Karakatsoulis G, Meggendorfer M, Parker H, Nadeu F, Brieghel C, Laidou S, Moia R, Rossi D, Catherwood M, Kotaskova J, Delgado J, Rodríguez-Vicente AE, Benito R, Rigolin GM, Bonfiglio S, Scarfo L, Mattsson M, Davis Z, Gogia A.et al Correction: Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY.Leukemia. 2023 Feb;37(2):504.

• Mansouri L, Thorvaldsdottir B, Sutton LA, Karakatsoulis G, Meggendorfer M, Parker H, Nadeu F, Brieghel C, Laidou S, Moia R, Rossi D,Catherwood M, Kotaskova J, Delgado J, Rodríguez-Vicente AE, Benito R, Rigolin GM, Bonfiglio S, Scarfo L, Mattsson M, Davis Z, Gogia A.et al Correction: Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status:a study by ERIC in HARMONY. Leukemia. 2023 Feb;37(2):504. doi: 10.1038/s41375-023-01813-3. Erratum for: Leukemia. 2023 Feb;37(2):339-347. PMID: 36635392; PMCID: PMC9898025.

• Pandey P, Kumar A, Pushpam D, Khurana S, Malik PS, Gogia A.Arunmozhimaran E, Singh MB, Chandran DS, Batra A. Randomized double-blind, placebo-controlled study of oral gabapentin for prevention of neuropathy in patients receiving paclitaxel. Trials. 2023 Feb 3;24(1):79. doi: 10.1186/s13063-023-07126-1. PMID: 36732774; PMCID: PMC9896696

• Mansouri L, Thorvaldsdottir B, Sutton LA, Karakatsoulis G, Meggendorfer M, Parker H, Nadeu F, Brieghel C, Laidou S, Moia R, Rossi D, Catherwood M, Kotaskova J, Delgado J, Rodríguez-Vicente AE, Benito R, Rigolin GM, Bonfiglio S, Scarfo L, Mattsson M, Davis Z, Gogia A.et al. Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY. Leukemia. 2023 Feb;37(2):339-347. doi: 10.1038/s41375-022-01802-y. Epub 2022 Dec 24.Erratum in: Leukemia. 2023 Jan 12;: PMID: 36566271; PMCID: PMC9898037.

• Dhar A, Srivastava A, Pandey RM, Shrestha P, Villet S, Gogia A.Safety and Efficacy of a Mobiderm Compression Bandage During Intensive Phase of Decongestive Therapy in Patients with Breast Cancer-Related Lymphedema: A Randomized Controlled Trial.Lymphat Res Biol. 2023 Feb;21(1):52-59.

• Rana R, Ranjan V, Kumar N, Chugh P, Khillan K, Gogia A.Rana DS, Ganguly NK.
  Association of underlying comorbidities and progression of COVID-19 infection amongst 2586 patients hospitalised in the National Capital Region of India: a retrospective cohort study.Mol Cell Biochem. 2023 Jan;478(1):149-160.

• Ganguly S, Gogia A.Overall survival with osimertinib in resected EGFR-mutated non-small-cell lung cancerCancer Research, Statistics, and Treatment 6 (4) (2023), 640-641

• Pandey P, Gogia A.Fifteen-year outcomes in prostate cancerCancer Research, Statistics, and Treatment 6 (4) (2023), 635-636

• Mane P, Ramteke P, Singh A, Gogia A.Mallick S,Primary extranodal NK/T cell lymphoma of stomach: A case report and review of literature Indian Journal of Pathology and Microbiology, (2023)10.4103

• Pandey P, Gogia A.Time to question extended adjuvant endocrine therapy for allCancer Research, Statistics, and Treatment 6 (4),(2023) 636-637

• Ganguly S, Gogia A.Perioperative nivolumab and chemotherapy in resectable Stage III non-small-cell lung cancerCancer Research, Statistics, and Treatment 6 (2023)(4), 643

• Ganguly S, Gogia A.Omitting radiation in early-stage breast cancerCancer Research, Statistics, and Treatment 6 (2023)(4), 642-643

• Pandey P, Gogia. AVeneto clax in chronic lymphocytic leukemiaCancer Research, Statistics, and Treatment 6 (2023) (4), 638

• Ganguly S, Gogia A. Capivasertib in advanced hormone receptor-positive breast cancerCancer Research, Statistics, and Treatment 6 (2023)(4), 633

• Pandey P, Gogia A. Sacituzumab govitecan: A narrative drug reviewCancer Research, Statistics, and Treatment 6 (4)(2023), 562-572

• Ganguly S, Gogia A.Preoperative treatment in locally advanced rectal cancerCancer Research, Statistics, and Treatment 6 (4)(2023), 641-642

• Ganguly S, Gogia A. Pembrolizumab in advanced endometrial cancerCancer Research, Statistics, and Treatment 6 (4)(2023), 631-632

• R Pramanik, S Vats, S Mitra, SVS Deo, L Kumar, Gogia. A, Khurana S,et al Assessment of Knowledge and Attitude of Breast and Ovarian Cancer Patients Regarding Hereditary Breast-Ovarian Cancer Syndrome at a Tertiary Cancer Institute: A Cross-Sectional studyIndian Journal of Medical and Paediatric Oncology 2023

• Pandey P, Gogia A.Sequencing therapies for metastatic hormone receptor-positive breast cancerCancer Research, Statistics, and Treatment (2023)6 (4), 639

• Pandey P, Gogia A. Anthracycline-and taxane-containing chemotherapy for early-stage breast cancer, Cancer Research, Statistics, and Treatment 6 (4) (2023), 633-634

• Pandey P, Gogia A. Protocol amendment in clinical trialsCancer Research, Statistics, and Treatment 6 (4)(2023), 645

• Ganguly S, Gogia A. Perioperative pembrolizumab in early-stage non-small-cell lung cancerCancer Research, Statistics, and Treatment 6 (4)(2023), 644

• Pandey P, Gogia A. Empowering breast cancer survivors: Nurturing self-compassion for a positive body image Cancer Research, Statistics, and Treatment 6 (4) (2023), 581-583

• Pandey P, Gogia. A Cabozantinib plus nivolumab and ipilimumab in renal cell carcinomaCancer Research, Statistics, and Treatment 6 (4)(2023), 635

• Ganguly S, Gogia A. Dostarlimab in recurrent endometrial cancerCancer Research, Statistics, and Treatment 6 (4)(2023), 632

• Upadhya S, Gogia A. Interrupting endocrine therapy in hormone-positive early breast cancerCancer Research, Statistics, and Treatment 6 (4), (2023) 639-640

• Pandey P, Gogia A. Rucaparib in metastatic prostate cancerCancer Research, Statistics, and Treatment 6 (2) (2023), 360-361.

• Chib S, Gogia.A Apatinib plus pegylated liposomal doxorubicin in platinum-resistant recurrent ovarian cancer Cancer Research, Statistics, and Treatment 5 (4), 793-794 (2023)

• Pandey P, Gogia A. Neoadjuvant pembrolizumab in advanced melanoma Cancer Research, Statistics, and Treatment 6 (2)(2023), 360

• Mallick S, Pandey P, Gogia A. Breast-conserving surgery without irradiation in early breast cancer ,Cancer Research, Statistics, and Treatment 6 (2)(2023), 361-362

• Oberoi AS, Deo SVS, Bhoriwal S, Sharma DN, Gogia.A, Mathur S.Treatment patterns in breast cancer: Real world data audit from tertiary care cancer center in LMICEuropean Journal of Surgical Oncology 49 (5) 2023, e230-e231

• Jain S, Ramteke P, Gogia A.Mandal T, Aggarwal M, Dass J, Sharma MC, Mahapatra M, Parmanik R, Bakhshi S, Sharma A, Mallick S. Splenic Lymphomas: A Tertiary Care Center Experience and Review of Literature. Indian J Hematol Blood Transfus. 2023 Jul;3 9(3):402-412. doi: 10.1007/s12288-022-01621-2. Epub 2022 Dec 28. PMID: 37304493; PMCID: PMC10247621.

• Ganguly S, Gogia A.Pembrolizumab as adjuvant therapy in non-small-cell lung cancer. Lancet Oncol. 2022 Dec;23(12):e528. doi: 10.1016/S1470-2045(22)00652-0. PMID: 36455577.

• Tarigopula V, Nayak P, Mandal S, Das MK, Tripathy S.Gogia A.Clarification needed for pembrolizumab as adjuvant therapy in clear cell renal cell carcinoma. Lancet Oncol. 2022 Nov;23(11):e487. doi: 10.1016/S1470-2045(22)00601-5. PMID: 36328016.

• Ganguly S, Gogia A.Clarification needed for pembrolizumab as adjuvant therapy in clear cell renal cell carcinoma.Lancet Oncol. 2022 Nov;23(11):e488. doi: 10.1016/S1470-2045(22)00602-7.PMID: 36328017 No abstract available.

• Jain S, Mandal T, Ramteke P, Sharma MC, Gogia A.Aggarwal M, Bakhshi S, Mallick S.Application of the Proposed Immunohistochemistry Algorithm for the Prognostication of GATA3 and TBX21 Subtypes of Peripheral T-Cell Lymphoma, Not Otherwise Specified.Clin Lymphoma Myeloma Leuk. 2022 Oct;22 Suppl 2:S398.

• Chib S, Gogia A.Doxorubicin plus trabectedin for metastatic or unresectable leiomyosarcoma.Lancet Oncol. 2022 Oct;23(10):e443.

• Ganguly S, Gogia A.PD-1 Blockade in Mismatch Repair-Deficient Rectal Cancer.N Engl J Med. 2022 Sep 1;387(9):855.

• Kumar R, Ningombam SS, Kumar R, Goel H, Gogia A.Khurana S, Deo SVS, Mathur S, Tanwar P.Comprehensive mutations analyses of FTO (fat mass and obesity-associated gene) and their effects on FTO's substrate binding implicated in obesity.FrontNutr. 2022 Jul 18;9:852944.

• Gupta G, Garg V, Mallick S, Gogia A.Current trends in diagnosis and management of follicular lymphoma. Am J Blood Res. 2022 Aug 15;12(4):105-124. PMID: 3647608; PMCID: PMC9490109.

• Mittal A, Deo SVS, Gogia A.Batra A, Kumar A, Bhoriwal S, Deb KS, Dhamija E, Ramprasad VL, Olopade O, Pramanik R. Spectrum and management of breast cancer patients with variant of uncertain significance mutations at a tertiary care centre in North India. Ecancermedicalscience. 2022 Aug 1;16:1434. doi: 10.3332/ecancer.2022.1434. PMID: 36200007; PMCID: PMC9470172.

• Pulappadi VP, Dhamija E, Baby A, Mathur S, Pandey P, Gogia A.Deo SVS. Imaging Features of Breast Cancer Subtypes on Mammography and Ultrasonography: an Analysis of 479 Patients. Indian J Surg Oncol. 2022 Dec;13 (4):931-938. doi: 10.1007/s13193-022-01606-7. Epub 2022 Aug 1. PMID: 36687228; PMCID: PMC9845486.

• Ganguly S, Gogia A.Capecitabine Maintenance in Metastatic Nasopharyngeal Carcinoma. JAMA Oncol. 2022 Aug 1;8(8):1223-1224. doi: 10.1001/jamaoncol.2022.2062. PMID: 35771541.

• Pulappadi VP, Dhamija E, Baby A, Mathur S, Pandey P, Gogia A.Deo SV. ImagingFeatures of Breast Cancer Subtypes on Mammography and Ultrasonography: anAnalysisof 479 Patients. Indian Journal of Surgical Oncology. 2022 Aug 1:1-8.

• Ganguly S, Gogia A.Rucaparib for recurrent ovarian cancer with BRCA1 and BRCA2 mutations. Lancet Oncol. 2022 Jul;23(7):e314. doi: 10.1016/S1470-2045(22)00325-4. PMID: 35772456.

• Pautier P, Italiano A, Piperno-Neumann S, Chevreau C, Penel N, Firmin N, Boudou-Rouquette P, Bertucci F, Balleyguier C, Lebrun-Ly V, Ray-Coquard I, Kalbacher E, Bardet A, Bompas E, Collard O, Isambert N, Guillemet C, Rios M, Archambaud B, Duffaud F; French Sarcoma Group. Doxorubicin alone versus doxorubicin with trabectedin followed by trabectedin alone as first-line therapy formetastatic or unresectable leiomyosarcoma (LMS-04): a randomised, multicentre, open-label phase 3 trial. Lancet Oncol. 2022 Aug;23(8):1044-1054. doi: 10.1016/S1470-2045(22)00380-1. Epub 2022 Jul 11. PMID: 35835135.

• Mukherjee Das A,Gogia A.Janardhanan R, Babu-Rajendran R, Das BC. EnvironmentalContamination and Chronic Exposure to Endocrine-Disrupting Phthalates: AnOverlooked and Emerging Determinant for Hormone-Sensitive Cancers. Journal of theIndian Institute of Science. 2022 Jul 20:1-2.

• Prasad CP, Batra A. Essential role of aerobic glycolysis in epithelial-to-mesenchymal Gogia A.transition during carcinogenesis. Clin Transl Oncol. 2022 Oct;24(10):1844-1855. doi: 10.1007/s12094-022-02851-6. Epub 2022 Jun 25. PMID: 35751743.

• Jain S, Mallick S, Ramteke P, Gogia A.Neoplasms of follicular helper T-cells: an insight into the pathobiology. Am J Blood Res. 2022 Jun 20;12 (3):64-81. PMID: 35873103; PMCID: PMC9301021.

• Mukherjee Das A, Gogia A.Garg M, Elaiyaraja A, Arambam P, Mathur S, Babu-Rajendran R, Deo SVS, Kumar L, Das BC, Janardhanan R. Urinary concentration of endocrine-disrupting phthalates and breast cancer risk in Indian women: A case-control study with a focus on mutations in phthalate-responsive genes. Cancer Epidemiol. 2022 Aug;7 9:102188. doi: 10.1016/j.canep.2022.102188. Epub 2022 Jun 7. PMID: 35688051.

• Kumar A, Baghmar S, Mehta P, Tiwari P, Kumar L, Bakhshi S, Agarwal A, Gupta I, Trikha A, Bhatnagar S, Gogia A.Characteristics& outcomes of cancer patients with COVID-19: A multicentre retrospective study from India.Indian J Med Res. 2022May-Jun;155(5&6):546-553.doi10.4103/ijmr.ijmr_1703_21.PMID: 36348601 

• Das N, Dahiya M, Gupta R, Rai S, Singh S, Prajapati VK, Kumar L, Sharma A, Sahoo RK, Gogia A.Flow cytometric immunophenotyping of plasma cells across the spectrum of plasma cell proliferative disorders: A fresh insight with pattern-basedrecognition. Cytometry B Clin Cytom. 2022 Jul;102(4):292-302. doi: 10.1002/cyto.b.22062. Epub 2022 Feb 25. PMID: 35212134.

• Pulappadi VP, Paul S, Hari S, Dhamija E, Manchanda S, Kataria K, Mathur S, Mani K, Gogia A.Deo S. Role of shear wave elastography as an adjunct to axillary ultrasonography in predicting nodal metastasis in breast cancer patients with suspicious nodes. Br J Radiol. 2022 Jun 1;95(1134):20220055. doi: 10.1259/bjr.20220055. Epub 2022 Mar 28. PMID: 35290097.

• Kumar A, Baghmar S, Mehta P, Tiwari P, Kumar L, Bakhshi S, Agarwal A, Gupta I, Trikha A, Bhatnagar S, Gogia A.Malik PS, Sahoo RK, Rastogi S, Pramanik R, Batra A, Pushpam D, Sharma CK, Sharma V, Kataria B, Goyal K, Samaga S, Bothra SJ, Sharma A. Characteristics & outcomes of cancer patients with COVID-19: A multicentre retrospective study from India. Indian J Med Res. 2022 May-Jun;15 5(5&6):546-553. doi: 10.4103/ijmr.ijmr_1703_21. PMID: 36348601; PMCID: PMC9807197.

• Santhosh A, Kumar A, Pramanik R, Gogia A.Prasad CP, Gupta I, Gupta N, Cheung WY, Pandey RM, Sharma A, Batra A. Randomized double-blind, placebo-controlled study of topical diclofenac in the prevention of hand-foot syndrome in patients receiving capecitabine (the D-TORCH study). Trials. 2022 May 19;23(1):420. doi: 10.1186/s13063-022-06353-2. PMID: 35590388; PMCID: PMC9117836.

• Gogia A.Gupta R, Sharma A, Kumar L, Rani L, Mallick S. Safety and Efficacy of Bendamustine and Rituximab (BR) Regimen in Indian Chronic Lymphocytic Leukaemia Patients. Indian J Hematol Blood Transfus. 2023 Jan;3 9(1):33-39. doi: 10.1007/s12288-022-01544-y. Epub 2022 May 27. PMID: 36699426; PMCID: PMC9868021.

• Santhosh A, Kumar A, Pramanik R, Gogia A.Prasad CP, Gupta I, Gupta N, Cheung WY, Pandey RM, Sharma A, Batra A.Randomized double-blind, placebo-controlled study of topical diclofenac in the prevention of hand-foot syndrome in patients receivingcapecitabine (the D-TORCH study). Trials. 2022 May 19;23(1):420. doi: 10.1186/s13063-022-06353-2. PMID: 35590388; PMCID: PMC9117836.

• Das N, Dahiya M, Gupta R, Kumar L, Sharma A, Rai S, Singh S, Prajapati VK, Sahoo RK, Gogia A. Relevance of polyclonal plasma cells and post-therapy immunomodulation in measurable residual disease assessment in multiple myeloma. Cytometry B Clin Cytom. 2022 May;10 2(3):209-219. doi: 10.1002/cyto.b.22068. Epub 2022 Apr 7. PMID: 35389550.Kumar S, Sharma A, Pramanik R, Pathak N, Gogia A.Kumar A, Kayal S, Sharma V, Sahoo RK, Thulkar S, Sharma MC, Gupta R, Mallick S, Thomas M, Raina V. Long-Term Outcomes and Safety Trends of Autologous Stem-Cell Transplantation in Non-Hodgkin Lymphoma: A Report From A Tertiary Care Center in India. JCO Glob Oncol. 2022 May;8:e2100383. doi: 10.1200/GO.21.00383. PMID: 35561291; PMCID: PMC9302266.

• Kumar S, Sharma A, Malik PS, Gogia A.Pathak N, Sahoo RK, Gupta R, Prasad CP, Kumar L. Bendamustine in combination with pomalidomide and dexamethasone in relapsed/refractory multiple myeloma: A phase II trial. Br J Haematol. 2022 Jul;198(2):288-297. doi: 10.1111/bjh.18200. Epub 2022 May 2. PMID: 35499209.

• Ganguly S, Gogia A.Pembrolizumab in Early Triple-Negative Breast Cancer. N Engl J Med. 2022 May 5;386(18):1771. doi: 10.1056/NEJMc2203316. PMID: 35507497.

• Gogia A.Deo S SV, Sharma DN, Mathur S. Oligometastatic breast cancer: An institutional analysis. Indian J Cancer. 2022 Apr-Jun;5 9(2):257-262. doi: 10.4103/ijc.IJC_169_20. PMID: 35946184.

• Lone M, Shadang M, Akhter Q, Kumar M, Mallick S, Gogia A.Nilima N, Chauhan SS, Mir RA. The Expression of the RUVBL1 Component of the R2TP Complex Correlates with Poor Prognosis in DLBCL. Pathobiology. 2022;89(3):146-156. doi: 10.1159/000520723. Epub 2022 Jan 25. PMID: 35078195.

• S Chib, Ganguly S, Gogia A.Neoadjuvant cemiplimab for stages II to IV cutaneous squamous cell carcinoma Cancer Research, Statistics, and Treatment 5 (4), (2022)799.

• Gogia A. Kumar S, Raina V, Sharma A, Gupta A, A Biswas, Mallick S :- ABCL-398 Primary Breast Diffuse Large B-Cell Lymphoma: An Indian Experience Clinical Lymphoma Myeloma and Leukemia (2022),S375-S376

• Chib S, Ganguly S, Gogia.A :- Neoadjuvantcemiplimabcemiplimab for stages II to IV cutaneous squamous cell carcinomaCancer Research, Statistics, and Treatment 5 (4), 799 (2022).

• Santhosh A, Gogia.A:- Is there an optimal regimen for double hit lymphomas?Cancer Research, Statistics, and Treatment 5 (4), 802-803 (2022)

• Ganguly S, S Bhargava, Gogia. A Brentuximab vedotin in pediatric Hodgkin lymphomaCancer Research, Statistics, and Treatment 5 (4), 800-801 (2022).

• Gogia.A. Kumar S, Raina V, Gupta R:- Poster: AML-194 Second Hematological Malignancies in Survivors of Breast Cancer: An Indian Institutional AnalysisClinical Lymphoma, Myeloma and Leukemia (2022), S130

• Gogia.A S Nair, Kumar S, Sharma A, A Biswas, S Mallik, Gupta R :-Poster: ABCL-200 Primary and Secondary Extranodal Diffuse Large B-Cell Lymphoma: A Single-Center Survey from IndiaClinical Lymphoma, Myeloma and Leukemia (2022), S167

• Gogia.A, Gupta R, Kumar l, Sharma A, L Rani, Mallick SPoster: IBCL-429 Prevalence of B-Cell Chronic Lymphoproliferative Disorders at a Large Tertiary Care Center in IndiaClinical Lymphoma, Myeloma and Leukemia (2022), S174

• Gogia.A Kumar S, Sharma A, Gupta R, Mallick S :- Poster: ABCL-400 Adult Burkitt Lymphoma: An Institutional Experience With Uniform DA-EPOCH-R ProtocolClinical Lymphoma, Myeloma and Leukemia (2022), S169

• Gogia.A, Kumar S, Raina V, Sharma A, Gupta R, Biswas A, Mallick S :-Poster: ABCL-398 Primary Breast Diffuse Large B-Cell Lymphoma: An Indian ExperienceClinical Lymphoma, Myeloma and Leukemia (2022), S169

• A Chaudhary, Gogia.A Gefitinib plus chemotherapy for EGFR-mutant non-small-cell lung cancerCancer Research, Statistics, and Treatment 5 (4), 796-797 (2022)

• Ganguly S, Gogia.A Triplet therapy, transplantation, and maintenance until progression in multiple myeloma Cancer Research, Statistics, and Treatment 5 (4), 801-802 (2022)

• Ganguly S, S Bhargva, Gogia.A:- Pembrolizumab as adjuvant therapy in melanoma Cancer Research, Statistics, and Treatment 5 (4), 799-800 (2022)

• Santhosh A, A.Gogia :- Is the Hans algorithm outdated?Cancer Research, Statistics, and Treatment 5 (4), 792-793 (2022)

• Das AM , Shrivastav KD, Taneja N , Awasthi AA , Rashid S , Gogia.A...Knowledge and awareness of breast cancer and breast self-examination among college-going female students in Delhi-NCR: a cross sectional studyHealth Education 122 (6), 663-677 (2022).

• Santhosh AP, A.Gogia. :- Is fulvestrant the correct choice for early switch with rising ESR1 mutation? Cancer Research, Statistics, and Treatment 5 (4), 798 (2022)

• Ganguly S, A.Gogia. :- Overall survival with brentuximab vedotin in advanced Hodgkin lymphoma Cancer Research, Statistics, and Treatment 5 (4), 794-795

• Pandey P, Gogia.A:- Ibrutinib plus bendamustine and rituximab in untreated mantle cell lymphomaCancer Research, Statistics, and Treatment 2022: 5 (3), 622 (2022)

• Ganguly.S, Gogia.A :- Trastuzumabderuxtecan in HER2-low breast cancer Cancer Research, Statistics, and Treatment 20225 (3), 621-622 (2022)

• Ganguly. S, Gogia.A :-Neoadjuvant nivolumab with chemotherapy in resectable lung cancer Cancer Research, Statistics, and Treatment 2022 5 (3), 620-621 (2022)

• Arora S, Gogia.A Tumour Lysis Syndrome Onco-critical Care: An Evidence-based Approach, 351-360 (2022)

• A Mukherjee Das, Gogia.A , Janardhanan R, R Babu-Rajendran, BC Das :-Environmental contamination and chronic exposure to endocrine-disrupting phthalates: an overlooked and emerging determinant for hormone-sensitive cancersJournal of the Indian Institute of Science 2022102 (2), 731-742 (2022)

• Gogia A. Kumar S, Raina V, Gupta A :AML-194 Second Hematological Malignancies in Survivors of Breast Cancer: An Indian Institutional Analysis Clinical Lymphoma Myeloma and Leukemia (2022), S223

• Gandhi AK, Gogia A. Authors' reply to Agarwal et al. and Iyer Cancer Research, Statistics, and Treatment 5 (1) (2022), 152-153

• Sharma R, Gogia A. Authors' reply to Muddu and Boindala Cancer Research, Statistics, and Treatment 5 (1) (2022), 183-184

• Tansir G, Gogia A. Gupta R. Hydroxyurea-induced hyperpigmentation. Cancer Res StatTreat2022;5:385-6.

• Pandey P, Gogia A. Axicabtageneciloleucel as second-line therapy for large B-celllymphoma. Cancer Res Stat Treat 2022;5:395.

• Gupta A, Gogia A. Lenvatinib plus pembrolizumab for advanced endometrial cancer.Cancer Res Stat Treat 2022;5:351.

• Sasi A, Gogia A. Preventing central nervous system relapses of diffuse large B-celllymphoma: A brief summary of current evidence. Cancer Res Stat Treat 2022;5:396-7.

• Kirar S, Gogia A. An unusual presentation of breast cancer: Upfront colonic and stomachmetastases. Cancer Res Stat Treat 2022;5:398-9.

• Ganguly S, Gogia A.Trastuzumab deruxtecan versus trastuzumab emtansine for breastcancer. Cancer Res Stat Treat 2022;5:393.

• Ganguly S, Gogia A. Overall survival with ribociclib and letrozole in advancedpostmenopausal hormone receptor–positive breast cancer. Cancer Res Stat Treat. 2022;5:393-4.

• Pandey P, Gogia A.Tisagenlecleucel in aggressive B-cell lymphoma. Cancer Res StatTreat2022;5:394-5.

• Gupta A, Gogia A. Ribociclib-induced flagellate rash. Cancer Res Stat Treat 2022;5:397-8.

• Ganguly S, Gogia A. reply to Kakoti and Laskar. Cancer Res Stat Treat2022;5:380-1.

• Goyal K, Gogia A. Ibrutinib-rituximab in Waldenstrom's macroglobulinemia. Cancer ResStat Treat 2022;5:351-2.

• Pandey P, Gogia A. Polatuzumabvedotin in previously untreated diffuse large B-celllymphoma. Cancer Res Stat Treat 2022;5:350.

• Kirar S, Gogia A. Gupta R. ATRA-induced myositis. Cancer Res Stat Treat 2022;5:386-388.

• Sharma A, Gogia A. Gupta R. Pleural effusion as an unusual presentation of chroniclymphocytic leukemia. Cancer Res Stat Treat 2022;5:388-9.

• Sharma R, Gogia A. Baa AK. Microbiota as a predictor of mortality in allogeneic hematopoietic cell transplantation. Cancer Res Stat Treat 2022;5:191-2.

• Nair SC, Gogia A. Arora S, Kumar L, Sharma A, Biswas A, Gupta R, Mallick S.Clinicopathologic features and outcomes of diffuse large B-cell lymphoma withextranodal involvement: A retrospective analysis. Cancer Res Stat Treat 2022;5:67-74.

• Gandhi AK, Gogia A. reply to Agarwal et al. and Iyer. Cancer Res Stat Treat2022;5:152-3.

• Ganguly S, Gogia A. Secondary cytoreductive surgery in recurrent ovarian carcinoma.Cancer Res Stat Treat 2022;5:192-3.

• Ganguly S, Gogia A.Relatlimab and nivolumab in untreated advanced melanoma.Cancer Res Stat Treat 2022;5:196-7.

• Ganguly S, Gogia A.Trastuzumab deruxtecan in HER2-mutant non-small-cell lungcancer. Cancer Res Stat Treat 2022;5:195-6.

• Sharma R, Gogia A. Reply to Muddu and Boindala. Cancer Res Stat Treat2022;5:183-4.

• Raodha R, Gogia A. Baa A. Adjuvant pembrolizumab in renal cell carcinoma. CancerRes Stat Treat 2022;5:191.

• Baa AK, Gogia A.Vemurafenib plus rituximab in relapsed or refractory hairy cellleukemia. Cancer Res Stat Treat 2022;5:188.

• Gogia A.Nair S, Arora S, Kumar L, Sharma A, Gupta R, Biswas A, Mallick S. Impact of Cell-of-Origin on Outcome of Patients With Diffuse Large B-Cell Lymphoma Treated With Uniform R-CHOP Protocol: A Single-Center Retrospective Analysis From North India. Front Oncol. 2021 Dec 2;11:770747. doi: 10.3389/fonc.2021.770747. PMID: 34926277; PMCID: PMC8675100.

• Deo SV, Chhebbi M, Mishra A, Sharma J, Gogia A. Pramanik R. A Review of SurgicalPerspectives of Breast Cancer Genetics and Risk-Reducing Surgery. Indian Journal ofSurgery. 2021 Nov 25:1-6.

• Mittal A, Deo SVS, Gogia A. Batra A, Kumar A, Bhoriwal S, Deb KS, Dhamija E, Thulkar S, Ramprasad VL, Olopade O, Pramanik R. Profile of Pathogenic Mutations and Evaluation of Germline Genetic Testing Criteria in Consecutive Breast Cancer Patients Treated at a North Indian Tertiary Care Center. Ann Surg Oncol. 2022 Feb;29(2):1423-1432. doi: 10.1245/s10434-021-10870-w. Epub 2021 Oct 2. PMID: 34601666; PMCID: PMC8487333.

• Ganguly S, Gogia A.Sacituzumab Govitecan in Metastatic Breast Cancer. N Engl J Med.2021 Jul 15;385(3):e12.

• Ganguly S, Gogia A.Adjuvant olaparib in germline BRCA-mutated breastcancer–Standard of care for all?. Cancer Research, Statistics, and Treatment. 2021 Jul1;4(3):600.

• Ganguly S, Gogia A.Extending adjuvant endocrine therapy in hormone receptor-positivebreast cancer: An Indian perspective. Cancer Research, Statistics, and Treatment. 2021Jul 1;4(3):602.

• Arundhathi JRD, Mathur SR, Gogia A.Deo SVS, Mohapatra P, Prasad CP. Metabolicchanges in triple negative breast cancer-focus on aerobic glycolysis. Mol Biol Rep. 2021 May;48(5):4733-4745

• Sharma A, Kumar S, A. Gogia, Gupta R, Thulkar S, Pramanik R, Sharma MC, Raina V. Autologous Stem Cell Transplant in Non Hodgkin Lymphoma at Aiims: Trends in Tolerability And Long Term Outcomes. In Bone Marrow Transplantation 2021 Jun 1 (Vol. 56, No. Suppl 1, Pp. 279-280). Campus, 4 Crinan St, London, N1 9xw, England: Springernature.

• Jain S, Lone MR, Goswami A, Mandal T, Panda AK, Ramteke P, Srivastav T, SharmaMC, Gogia A.Sharma A, Bakhshi S, Mahapatra M, Kumar L, Mallick S. Lymphomasubtypes in India: a tertiary care center review. Clin Exp Med. 2021 May;21(2):315-321

• Gogia A.Mittal A, Sharma A, Sagiraju HKR. Short-duration adjuvant trastuzumabtherapy in human epidermal growth factor receptor 2-positive breast cancers: Has its timecome? Natl Med J India. 2021 Mar-Apr;34(2):90-91. doi: 10.4103/0970-258X.326770.

• Gogia A.Kumar S, Chellapurum SK, Biswas A, Mallick S. Primary Mediastinal B CellLymphoma: A Limited Institutional Experience with Uniform DAEPOCH-R Protocol.Indian J Hematol Blood Transfus. 2021 Jan;37(1):176-178. doi: 10.1007/s12288-020

• Mishra S, Gogia A.Satapathy S, GOGIA A.Sharma A, Bhatnagar S. Caregiver Burden andQuality of Life among Family Caregivers of Cancer Patients on Chemotherapy: AProspective Observational Study. Indian J Palliat Care. 2021 Jan-Mar;27(1):109-112.

• Arora S, Gogia A.Recent updates in systemic therapy of breast cancer: A brief narrativereview. Cancer Research, Statistics, and Treatment. 2021 Jan 1;4(1):99.

• Arora S, Gogia A.Deo S, Sharma D, Mathur SR. Neoadjuvant pertuzumabplustrastuzumab in combination with anthracycline- free chemotherapy regimen in patientswith HER2 positive breast cancer-Real-world data from a single center in India. CancerTreat Res Commun. 2021; 29:100483. doi: 10.1016/j.ctarc.2021.100483.

• Pulappadi VP, Paul S, Hari S, Dhamija E, Manchanda S, Kataria K, Mathur S, Mani K, Gogia A.Deo S. Axillary ultrasonography combined withpre-operative wire localisation of clipped node in nodal restaging after neoadjuvant chemotherapy in node positive breast cancer patients:a pilot study. Br J Radiol. 2021 Nov 1;94(1127):20210788. doi: 10.1259/bjr.20210788. Epub 2021 Sep 7. PMID: 34491822; PMCID: PMC8553197.

• Das N, Gupta R, Gupta SK, Bakhshi S, Seth R, Kumar C, Rai S, Singh S, Prajapati VK, Gogia A.Sahoo RK, Sharma A, Kumar L. Critical evaluation of the utility of pre- and post-therapy immunophenotypes in assessment of measurable residual disease in B-ALL. Ann Hematol. 2021 Oct;100(10):2487-2500. doi: 10.1007/s00277-021-04580-2. Epub 2021 Jul 8. PMID: 34236495.

• Ganguly S, Gogia A.Sacituzumab Govitecan in Metastatic Breast Cancer. N Engl J Med. 2021 Jul 15;385(3):e12. doi: 10.1056/NEJMc2108478. PMID: 34260847.

• Ganguly S, Gogia A.Pembrolizumab monotherapy in advanced triple-negative breast cancer. Lancet Oncol. 2021 Jun;22(6):e224. doi: 10.1016/S1470-2045(21)00249-7. PMID: 34087134.

• Dhamija E, Gulati M, Deo SVS, Gogia A.Hari S. Digital Breast Tomosynthesis: an Overview. Indian J Surg Oncol. 2021 Jun;12(2):315-329. doi: 10.1007/s13193-021-01310-y. Epub 2021 May 15. PMID: 34295076; PMCID: PMC8272763.

• Bhoriwal S, Deo SVS, Kumar R, Thulkar S, Gogia A.Sharma DN, Mathur S.A Prospective Study Comparing the Role of 18 FDG PET-CTwith Contrast-Enhanced Computed Tomography and Tc99m Bone Scan for Staging LocallyAdvanced Breast Cancer. Indian J Surg Oncol. 2021 Jun;12(2):266-271. doi: 10.1007/s13193-021-01299-4. Epub 2021 Mar 2. PMID: 34295069; PMCID: PMC8272774.

• Ganguly S, Gogia A.Adjuvant olaparib in germline BRCA-mutated breast cancer–Standard of care for all? Cancer Research, Statistics, and Treatment 4 (3)(2021), 600-601

• Ganguly S, Gogia A.Extending adjuvant endocrine therapy in hormone receptor-positive breast cancer: An Indian perspective Cancer Research, Statistics, and Treatment 4 (3), 602-603(2021).

• Choudhary P, Gogia A.Deo S V, Sharma D, Mathur SR, Batra A, Raju SagirajuHK. Correlation of pathological complete response with outcomes in locally advanced breastcancer treated with neoadjuvant chemotherapy: An ambispective study. Cancer Res StatTreat2021;4:611-20.

• Sharma RK, Gogia A.Management of triple-negative breast cancer in the era of noveltherapies: A narrative review. Cancer Res Stat Treat 2021;4:668-76.

• Ganguly S, Gogia A.Cabozantinib for radioiodine-refractory progressive differentiatedthyroid cancer. Cancer Res Stat Treat 2021;4:806.

• Sasi A, Gogia A.Nivolumab in relapsed malignant mesothelioma: Is it ‘CONFIRM’ed?.Cancer Res Stat Treat 2021;4:809-10.

• Ganguly S, Gogia A.Pembrolizumab in recurrent or metastatic cervical cancer. CancerRes Stat Treat 2021;4:808-9.

• Kumar S, Gogia A.Gupta R, Mallick S. Chronic Lymphocytic Leukemia withDermatomyositis: A Therapeutic Challenge. Turk J Haematol. 2020 Nov 19;37(4):291

• Vanidassane I, Gogia A.Raina V, Tiwari P. Breast cancer associated with paraneoplastic cerebellar degeneration: A case series.Indian J Cancer. 2020 Oct-Dec;57(4):487-488. doi: 10.4103/ijc.IJC_132_19.PMID: 33078760 No abstract available.

• Kirar S, Gogia A.Gupta R, Mallick S. Ibrutinib-Induced Skin Rash. Turk J Haematol.2021 Feb 25;38(1):81-83. doi: 10.4274/tjh.galenos.2020.2020.0120. Epub 2020 Oct 15.

• Umar SM, Kashyap A, Kahol S, Mathur SR, Gogia A.Deo SVS, Prasad CP. Prognostic and therapeutic relevance of phosphofructokinase platelet-type (PFKP) in breast cancer.Exp Cell Res. 2020 Nov 1;396(1):112282. doi: 10.1016/j.yexcr.2020.112282. Epub 2020 Sep 11.PMID: 32919954

• Mittal A, GOGIA A.Mallick S. Diffuse Large B-Cell Lymphoma presenting as isolated pleural effusion with excellent response to R-PEPC regimen. Indian J Cancer. 2020 Jul-Sep;57(3):351-353

• Gogia A.Kumar S, Kumar L, Sharma A, Mallick S. Safety and Efficacy ofBendamustine-Rituximab in Treatment Naïve Symptomatic Follicular Lymphoma: AnInstitutional Analysis. Indian J Hematol Blood Transfus. 2021 Jan;37(1):169-170. doi:1007/s12288-020-01294-9. Epub 2020 Jun 9. PMID: 33707853; PMCID:

• Das N, Gupta R, Gupta SK, Bakhshi S, Malhotra A, Rai S, Singh S, Prajapati VK, Sahoo RK, Gogia A.Sharma A, Kumar L. A Real-world Perspective of CD123 Expression in Acute Leukemia as Promising Biomarker to Predict Treatment Outcome in B-ALL and AML.ClinLymphoma Myeloma Leuk. 2020 Oct;20(10):e673-e684. doi: 10.1016/j.clml.2020.05.004. Epub 2020 May 11.PMID: 32561191

• SK Chellapuram, Gogia A.Systemic therapy for breast cancer during SARS-CoV-2 pandemic Cancer Research, Statistics, and Treatment. 2020; 3 (5), 35

• S Arora and Gogia A. Cutaneous T-cell lymphoma. The Journal of Medical Research. 2020; 152 (Suppl 1), S48

• A Mittal, Gogia A. Adding ovarian suppression to tamoxifen for pre-menopausal breast cancer. National Medical Journal of India, 2020. 33(5)

• SK Chellapuram, Gogia A. Authors' reply to D'Souza et al. Cancer Research, Statistics, and Treatment. 2020; 3 (2), 334

• A Garg, Gogia A. Mallick S, Gupta A. B-Acute lymphoblastic leukemia in a follow-up case of breast cancer. Indian Journal of Medical and Paediatric Oncology. 2020; 41 (01), 99-101

• Gogia A. Deo SVS, Sharma D, Phulia RK, Thulkar S, Malik PS, Mathur S.Discordance in Biomarker Expression in Breast Cancer After Metastasis: Single Center Experience in India.J Glob Oncol. 2019 Apr;5:1-8. doi: 10.1200/JGO.18.00184.

• Gogia A. Deo SVS, Sharma D, Thulkar S, Kumar R, Malik PS, Mathur S.Clinicopathologic Characteristics and Treatment Outcomes of Patients With Up-Front Metastatic Breast Cancer: Single-Center Experience in India.J Glob Oncol. 2019 Mar;5:1-9. doi: 10.1200/JGO.18.00265.

• Singh A, Purkait S, Mallick S, Ramteke P, Das CK, Gogia A.Sharma MC, Kumar L.Clinicopathological Profile of Castleman's Disease in Indian Population: Experience from a Tertiary Care Center.Indian J Hematol Blood Transfus. 2020 Apr;36(2):254-259.

• Singh A, Purkait S, Mallick S, Ramteke P, Das CK, Gogia A. Sharma MC, Kumar L. Clinicopathological Profile of Castleman's Disease in Indian Population: Experience From a Tertiary Care Center.Indian J Hematol Blood Transfus. 2020 Apr;36(2):254-259

• Kaur G, Ruhela V, Rani L, Gupta A, Sriram K, Gogia A.Sharma A, Kumar L.RNA-Seq profiling of deregulated miRs in CLL and their impact on clinical outcome.Blood Cancer J. 2020 Jan 13;10(1):6. doi: 10.1038/s41408-019-0272-y.PMID: 31932582  

• Sood, A., Ranjan, P., Gogia A.et al. Gentle Chemotherapy in Breast Cancer. Indian J Surg (2020).

• Das N, Thakral D, Singh G, Malhotra A, Phulware RH, Gogia A.Gupta R.FLI1 and MIC2 expression in precursor B-lymphoblastic leukemia with Burkitt-like morphology and extensive extramedullary involvement: A diagnostic challenge in pediatric small round cell tumor.Indian J PatholMicrobiol. 2019 Oct-Dec;62(4):614-617. doi: 10.4103/IJPM.IJPM_520_18.

• Vanidassane I, Gogia A.Mallick S.Adult ALK-positive diffuse large B-cell lymphoma: A limited institutional experience.Indian J Cancer. 2019 Oct-Dec;56(4):373-374. doi: 10.4103/ijc.IJC_705_18.

• Pramanik R, Sharma A, Sharma A, Gogia A.Sahoo RK, Malik PS, Padma MV, Cyriac SL, Kumar L.POEMS Syndrome: Indian Experience from a Tertiary-Care Institute.Clin Lymphoma Myeloma Leuk. 2019 Sep;19(9):e536-e544. doi: 10.1016/j.clml.2019.05.018

• Vanidassane I, Gogia A.Raina V, Gupta R.Treatment Related Acute Myeloid Leukemia in Breast Cancer Survivors: A Single Institutional Experience.Indian J Hematol Blood Transfus. 2019 Jul;35(3):561-562. doi: 10.1007/s12288-019-01078-w. Epub 2019 Feb 4.

• Kumar R, Kumar S, Gogia A.Kakkar A, Mathur SR.Laryngeal metastases from breast cancer: A rare clinical entity.CurrProbl Cancer. 2019 Apr;43(2):130-134. doi: 10.1016/j.

• Mittal A, Gogia A.Mallick S, Gupta R.Leukemia Cutis: A Rare Initial Presentation of Chronic Lymphocytic Leukemia.Indian J Hematol Blood Transfus. 2019 Apr;35(2):367-368. doi: 10.1007/s12288-018-1057-3.

• Garg V, Gogia A.Gupta G.Upfront Lenalidomide in Follicular Lymphoma: Time has Come or Not?Indian J Hematol Blood Transfus. 2019 Apr;35(2):362-363. doi: 10.1007/s12288-018-1046-6.

• Patekar M, Adhikari N, Biswas A, Raina V, Kumar L, Mohanti BK, Gogia A.Sharma A, Batra A, Bakhshi S, Garg A, Thulkar S, Sharma MC, Vishnubhatla S, Baghmar S, Sahoo RK.Primary CNS Lymphoma in India: A 17-Year Experience from the AllIndia Institute of Medical Sciences.J Glob Oncol. 2019 Feb;5:1-9. doi: 10.1200/JGO.18.00124.

• Gogia A.Gupta R, Kumar L, Sharma A, SoniL.Chronic lymphocytic leukemia with deletion 17p: An Indian scenario.South Asian J Cancer. 2019 Jan-Mar;8(1):40. doi: 10.4103/sajc.sajc_287_18.

• A Kakkar, S Purkait, S Agarwal, Mallick S, Gogia A. AK Karak, MC Sharma.Primary thyroid lymphoma: A series from a tertiary care center in Northern India. Journal of cancer research and therapeutics 15 (3), 669 2019

• I Vanidassane, Gogia A. V Sharma, Mallick S. Hodgkin Variant of Richter's Transformation: Is Transplant Always an Answer?.Indian Journal of Medical and Paediatric Oncology. 2019; 40 (02), 307-308

• Sharma M, Gogia A. Deo SSV, Mathur S.Role of re-biopsy in metastatic breast cancer at progression.CurrProbl Cancer. 2019 Oct;43(5):438-442. doi: 10.1016/j.currproblcancer.2018.12.001. Epub 2018 Dec 10.

• Francis Thottian AG, Gandhi AK, Ramateke PP, Gogia A..Acinic cell carcinoma of parotid gland with cavernous sinus metastasis: A case report.J Cancer Res Ther. 2018 Oct-Dec;14(6):1428-1430. doi: 10.4103/0973-1482.192850.

• Gogia A. Raina V, Deo SVS, Shukla NK, Mathur S, Mohanti BK, Sharma DN.Clinico-pathological characteristics and treatment outcome in invasive lobular carcinoma of the breast: An Indian experience.Indian J Cancer. 2018 Oct-Dec;55(4):344-347. doi: 10.4103/ijc.IJC_428_18.

• Gogia A. Deo SV, Shukla NK, Mathur S, Sharma DN, Tiwari A.Clinicopathological profile of breast cancer: An institutional experience.Indian J Cancer. 2018 Jul-Sep;55(3):210-213. doi: 10.4103/ijc.IJC_73_18.

• Vanidassane I, Gogia A.Kumar L.Contemporary hormonal contraceptives and breast cancer risk: What do we learn?. Natl Med J India. 2018 May-Jun;31(3):156-157. doi: 10.4103/0970-258X.255759. No abstract available.

• Rani L, Gogia A.Singh V, Kumar L, Sharma A, Kaur G, Gupta R.Comparative assessment of prognostic models in chronic lymphocytic leukemia: evaluation in Indian cohort.AnnHematol. 2019 Feb;98(2):437-443. doi: 10.1007/s00277-018-3525-0. Epub 2018 Oct 18.

• Nair R, Kakroo A, Bapna A, Gogia A.Vora A, et al. Management of Lymphomas: Consensus Document 2018 by an Indian Expert Group.Indian J Hematol Blood Transfus. 2018 Jul;34(3):398-421. doi: 10.1007/s12288-018-0991-4. Epub 2018 Aug 3.

• Gupta VG, Gogia A. Sharma V, MallickS.LymphomatoidGranulomatosis with Isolated Cutaneous Lesions: Prolonged Remission After DA-EPOCH ProtocolTurk J Haematol. 2018 Aug 3;35(3):213-214

• Natarajan H, Kumar L, Bakhshi S, Sharma A, Velpandian T, Kabra M, Gogia A. Ranjan Biswas N, Gupta YK.Imatinib trough levels: a potential biomarker to predict cytogenetic and molecular response in newly diagnosed patients with chronic myeloid leukemia.Leuk Lymphoma. 2019 Feb;60(2):418-425. doi: 10.1080/10428194.2018.1485907. Epub 2018 Aug 20.

• Adhikari N, Biswas A, Gogia A. Sahoo RK, Garg A, Nehra A, Sharma MC, Bhasker S, Singh M, Sreenivas V, Chawla R, Joshi G, Kumar L, Chander S.A prospective phase II trial of response adapted whole brain radiotherapy after high dose methotrexate based chemotherapy in patients with newly diagnosed primary central nervous system lymphoma-analysis of acute toxicity profile and early clinical outcome.JNeurooncol. 2018 Aug;139(1):153-166.

• Gogia A.Das CK, Kumar L, Sharma A, Tiwari A, Sharma MC, Mallick S. Profile of non-Hodgkin lymphoma: An Indian perspective. South Asian J Cancer 2018 7 (3), 162-163.

• Gogia A.Das CK, Kumar L, Sharma A, Tiwari A, Sharma MC, Mallick S. Diffuse large B-cell lymphoma: An institutional analysis South Asian J Cancer 2018; 7 (3), 200-202.

• Gogia A.Raina V, Deo SVS, Shukla NK, Mathur S, Sharma DN.Neoadjuvant chemotherapy in locally advanced invasive lobular carcinoma: A limited institutional experience.South Asian J Cancer. 2018 Jan-Mar;7(1):64-65.

• M Patekar, Gogia A. A Tiwari, Kumar L, Sharma A, SR Mallick. Adult Burkitt lymphoma: An institutional experience with a uniform chemotherapy protocol. South Asian Journal of Cancer. 2018; 7(03), 195-199

• Gogia A. J Nigade, C Desai, BK Govind, C Deshmukh, B Swarup. Trastuzumab emtansine: Antibody-drug conjugate in treatment of human epidermal growth factor receptor-2-positive metastatic breast cancer. Indian Journal of Medical and Paediatric Oncology. 2018; 39 (01), 79-87

• GuptaVG, Gogia A. KumarL, SharmaA, BakshiS, SharmaMC. Combined modality treatment with “dexamethasone, methotrexate, ifosfamide, l-asparaginase, and etoposide” chemotherapy and involved field radiotherapy. Indian Journal of Medical and Paediatric Oncology. 2018; 39(01), 67-72

• Das ChK, Gogia A. Kumar L, Sharma A, Sharma MCh, Mallick SR.Mantle Cell Lymphoma: A North Indian Tertiary Care Centre ExperienceAsian Pac J Cancer Prev. 2016 Oct 1;17(10):4583-4586.

• Harivenkatesh N, Kumar L, Bakhshi S, Sharma A, Kabra M, Velpandian T, Gogia A. Shastri SS, Gupta YK.Do polymorphisms in MDR1 and CYP3A5 genes influence the risk of cytogenetic relapse in patients with chronic myeloid leukemia on imatinibtherapy?Leuk Lymphoma. 2017 Sep;58(9):1-9.

• Harivenkatesh N, Kumar L, Bakhshi S, Sharma A, Kabra M, Velpandian T, Gogia A. Shastri SS, Biswas NR, Gupta YK.Influence of MDR1 and CYP3A5 genetic polymorphisms on trough levels and therapeutic response of imatinib in newly diagnosed patients with chronic myeloid leukemia.Pharmacol Res. 2017 Jun;120:138-145.

• Rani L, Mathur N, Gupta R, Gogia A. Kaur G, Dhanjal JK, Sundar D, Kumar L, Sharma A.Genome-wide DNA methylation profiling integrated with gene expression profiling identifies PAX9as a novel prognostic marker in chronic lymphocytic leukemia.Clin Epigenetics. 2017 May 30;9:57.

• Harivenkatesh N, Kumar L, Bakhshi S, Sharma A, Kabra M, Velpandian T, Gogia A. Shastri SS, Biswas NR, Gupta YK. Influence of MDR1 and CYP3A5 genetic polymorphisms on trough levels and therapeutic response of imatinib in newlydiagnosed patients with chronic myeloid leukemia. Pharmacol Res. 2017 Jun;120:138-145.

• Pramanik R, Gogia A. Malik PS.Metastatic Primary Angiosarcoma of the Breast: Can We Tame It the Metronomic Way.Indian J Med PaediatrOncol. 2017 Apr-Jun;38(2):228-231. doi: 10.4103/ijmpo.ijmpo_156_16.

• Gogia A. Raina V, Kumar L, Sharma A, Sharma MCh, Mallick SR.Follicular lymphoma: an Institutional Analysis. Asian Pac J Cancer Prev. 2017 Mar 1;18(3):681-685.

• Mittal A, Sharma S, Gupta VG, Ragesh R, Nischal N, Gogia A. Soneja M, Das CJ, Sharma SK.Carcinoma of Unknown Primary Presenting as Peripheral Symmetric Gangrene.JAssoc Physicians India. 2017 Feb;65(2):78-81.

• Khanna G, Damle NA, Agarwal S, Roy M, Jain D, Mallick S, Ahmed S, Tripathi M, Gogia A. Mixed Phenotypic Acute Leukemia (mixed myeloid/B-cell) with Myeloid Sarcoma of the Thyroid Gland: A Rare Entity with Rarer Asssociation - Detected on FDG PET/CT.Indian J Nucl Med. 2017 Jan-Mar;32(1):46-49.

• Kumar U, Ramteke P, Das P, Gogia A. TanwarP.Isolated bone marrow metastasis of testicular tumor: A rare cause of thrombocytopenia.Urol Ann. 2017 Jan-Mar;9(1):96-98

• Tiwari A, Gogia A. Deo S, Shukla NK, Mathur S, Sharma DN.Retrospective study of efficacy and safety of neoadjuvantdocetaxel, carboplatin, and trastuzumab in HER2-positive locally advanced and oligometastatic breast cancer: An Indian experience.Indian J Cancer. 2017 Jan-Mar;54(1):343-346. doi: 10.4103/ijc.IJC_152_17.

• Meel R, Dhiman R, Wadhwani M, Kashyap S, Sharma S, Gogia A. IsolatedExtranodal Natural Killer T-Cell Lymphoma of the Orbit in a Young Patient: Complete Regression with the SMILE Regimen.OculOncolPathol. 2017 Jan;3(1):45-48.

• RAMT, KakkanattuTJ, KumarA, Gogia A. WigN. A Case of Idiopathic CD4 Lymphocytopenia (ICL): Immunological Mystery Leading to Storm of Diseases.Journal of Clinical & Diagnostic Research.2017; 11(12)

• SVDeo S, Shukla NK, Gogia A. DN SharmaAJakhetiya, DK Muduly. A comparative study of clinical profile and relapse patterns in triple-negative and non-triple-negative breast cancer patients treated with curative intent. Indian Journal of Surgical Oncology.2017; 8(3), 291-297

• Vallonthaiel AG, Kaushal S, Gogia A. Mathur SR.Bilateral Myeloid Sarcoma of Breast in a Young Male Occurring after 11 Years of Chronic Myeloid Leukemia Diagnosis: A Unique Pattern of Relapse.Breast J. 2016 Nov;22(6):692-693.

• Rani L, Mathur N, Gogia A.Vishnubhatla S, Kumar L, Sharma A, Dube D, Kaur P, Gupta R.Immunoglobulin heavy chain variable region gene repertoire and B-cell receptor stereotypes in Indian patients with chronic lymphocytic leukemia.Leuk Lymphoma. 2016 Oct;57(10):2389-400

• Gupta VG, Gogia A. DDGP versus SMILE in NK/T-Cell Lymphoma-Letter.Clin Cancer Res. 2016 Aug 15;22(16):4271

• Garg PK, Deo SV, Kumar R, Shukla NK, Thulkar S, Gogia A.Sharma DN, MathurSR.Staging PET-CT Scanning Provides Superior Detection of Lymph Nodes and Distant Metastases than Traditional Imaging in Locally Advanced Breast Cancer.World J Surg. 2016 Aug;40(8):2036-42.

• Ramteke P, Seenu V, Prashad R, Gupta SD, Iyer V, Deo S, Gogia A. Mathur S.Alteration in steroid hormone and Her-2/neu receptor status following neoadjuvant chemotherapy in locally advanced breast cancer: Experience at a tertiary care centre in India.Indian J Cancer. 2016 Jul-Sep;53(3):366-371.

• Reddy R, Gogia A. Kumar L, Sharma A, Bakhshi S, Sharma MC, Mallick S, Sahoo R.HIV-associated hematologic malignancies: Experience from a Tertiary Cancer Center in India.Indian J Med Paediatric Oncol. 2016 Jul-Sep;37(3):141-5.

• Pramanik R, Sahoo RK, Gogia A. Neutropenia due to palbociclib: A word of caution? . Indian J Med PaediatrOncol. 2016 Jul-Sep;37(3):206

• Chopra A, Soni S, Pati H, Kumar D, Diwedi R, Verma D, Vishwakama G, Bakhshi S, Kumar S, Gogia A. Kumar R.Nucleophosmin mutation analysis in acute myeloid leukaemia: Immunohistochemistry as a surrogate for molecular techniques.Indian J Med Res. 2016 Jun;143(6):763-768

• Chharchhodawala T, Gajendra S, Tiwari P, Gogia A. Gupta R.Therapy Related Acute Myeloid Leukemia with t(8;16) Mimicking Acute PromyelocyticLeukemia.Indian J Hematol Blood Transfus. 2016 Jun;32(Suppl 1):20-2

• Roy S, Madan R, Gogia A. Tripathy K, Sharma D, Julka PK, RathGK.Short course palliative radiotherapy in the management of choroidal metastasis: An effective technique since ages.J Egypt NatlCanc Inst. 2016 Mar;28(1):49-53

• Mukherjee A, Agarwal KK, Gogia A. Bal C, Kumar R.Bilateral Renal Involvement in Mantle Cell Lymphoma on FDG PET/CT.ClinNucl Med. 2016 Apr;41(4):

• Chopra A, Soni S, Verma D, Kumar D, Dwivedi R, Vishwanathan A, Vishwakama G, Bakhshi S, Seth R, Gogia A. Kumar L, Kumar R.Prevalence of common fusion transcripts in acute lymphoblastic leukemia: A report of 304 cases.Asia Pac J ClinOncol. 2015 Dec;11(4):293-8.

• Kakkar A, Rajeshwari M, Bhethanabhotla S, Kaur K, Jain D Gogia A. Ray R, Seth A.Primary diffuse large B-cell lymphoma of the prostate: A report of two cases with diagnostic considerations.J Cancer Res Ther. 2015 Oct-Dec;11(4):977-9.

• Gogia A. Raina V, Deo SV, Shukla NK, Mohanti BK Male breast cancer: A single institute experience.Indian J Cancer. 2015 Oct-Dec;52(4):526-9

• Gogia A. Iqbal N, Sharma MC, RainaV.Isolated Richter's transformation of brain parenchyma: Remission with DeAngelisprotocol.Indian J Cancer. 2015 Jul-Sep;52(3):329-30.

• Iqbal S, Vishnubhatla S, Raina V, Sharma S Gogia A. .Deo SS, Mathur S, ShuklaNK.Circulating cell-free DNA and its integrity as a prognostic marker for breast cancer.Springerplus. 2015 Jun 17;4:265.

• Mallik N, Chopra A, Jha A, Gogia A. Kumar R.Development of myelodysplastic syndrome in a patient with chronic myelogenousleukemia treated with imatinib.Leuk Lymphoma. 2015 Apr;56(4):1143-4.

• Gogia A. Sharma A, Raina V, Chopra A.Superior vena cava syndrome: Initial presentation of acute myeloid leukemia in a child.Indian J Cancer. 2015 Jan-Mar;52(1):21

• Sahai P, Baghmar S, Nath D, Arora S, Bhasker S, Gogia A. Sikka K, Kumar R, Chander S.Extrapulmonary Small Cell Carcinoma - a Case Series of Oropharyngeal and Esophageal Primary Sites Treated with Chemo-Radiotherapy.Asian Pac J Cancer Prev. 2015;16(16):7025-9.

• Gogia A. Raina V, Gupta R, Gajendra S, Kumar L, Sharma A, Kumar R, VishnubhatlaS.Prognostic and predictive significance of smudge cell percentage on routine blood smear in chronic lymphocytic leukemia.Clin Lymphoma Myeloma Leuk. 2014 Dec;14(6):514-7.

• Gogia A. Mehta P, Pramanik R, Gupta R.Chronic lymphocytic leukemia with massive ascites: An unusual presenting manifestation.South Asian J Cancer. 2014 Oct;3(4):235-6.

• Gogia A. Raina V, Deo SV, Shukla NK, MohantiBK.Young breast cancer: A single centerexperience.Indian J Cancer. 2014 Oct-Dec;51(4):604-8

• Gajendra S, Gogia A. Das P, Gupta R, Tanwar P.Acute myeloid leukemia presenting as "bowel upset": a case report.JClinDiagn Res. 2014 Jul;8(7):FD09-10

• Gogia A. Raina V, Kumar L, Sharma A, Mehta P, Sharma MC.Diffuse large B-cell lymphoma in patients with chronic lymphocytic leukemia: A single centerexperience.South Asian J Cancer. 2014 Jul;3(3):186.

• Gogia A. Deo SV, Shukla NK, Mohanti BK, RainaV.Pregnancy associated breast cancer: an institutional experience.Indian J Cancer. 2014 Apr-Jun;51(2):167-9.

• Gogia A. Raina V, Deo SV, Shukla NK, Mohanti BK Triple-negative breast cancer: An institutional analysis.Indian J Cancer. 2014 Apr-Jun;51(2):163-6.

• Gogia A. Mehta P, Pramanik R, Kumar R.Isolated breast relapse mimicking breast cancer in elderly patient with acute lymphoblastic leukemia.Turk J Haematol. 2014 Jun;31(2):203-4

• Gogia A. Khurana S, ParamanikR.Acute myocardial infarction after first dose of rituximab infusion.TurkJHaematol. 2014 Mar;31(1):95-6. doi: 10.4274/Tjh.2013.0247

• Chopra A, Bakhshi S, Pramanik SK, Pandey RM, Singh S, Gajendra S, Gogia A. Chandramohan J, Sharma A, Kumar L, Seth R, Rai S, Kumar R.Immunophenotypic analysis of T-acute lymphoblastic leukemia.A CD5-based ETP-ALL perspective of non-ETP T-ALL.Eur J Haematol. 2014 Mar;92(3):211-8.

• Gogia A. Singh L, Karak AK, BakhshiS.Primarytonsillar Ewing sarcoma in young adult: A rare tumor at an uncommon site.Indian J Med PaediatrOncol. 2014 Jan;35(1):122-3.

• Gogia A. Raina V, Iqbal N, Murugan V.Spontaneoustumorlysis syndrome in a patient of chronic lymphocytic leukemia.Indian J Med PaediatrOncol. 2014 Jan;35(1):120

• Gogia A. Raina V, Deo SV, Shukla NK, Mohanti BK, Sharma DN.Inflammatory breast cancer: a single centre analysis.Asian Pac J Cancer Prev. 2014;15(7):3207-10.

• Gogia A. Raina V, Deo SV, Shukla NK, Mohanti BK, Sharma DN. Taxane and anthracycline based neoadjuvant chemotherapy for locally advanced breast cancer: institutional experience.Asian Pac J Cancer Prev. 2014;15(5):1989-92.

• Gogia A. Bansal A, Suri V, BakhshiS.Childhood orbital soft tissue sarcoma in xerodermapigmentosum with good tolerance to chemotherapy and radiotherapy.Pediatr Blood Cancer. 2013 Dec;60(12):2093-4.

• Gogia A. Sharma A, Raina V, Kumar L, Gupta R, Kumar R.Prevalence ofZAP-70 and CD 38 in Indian chronic lymphocytic leukemiapatients.Indian J Cancer. 2013 Oct-Dec;50(4):333-6.

• Gogia A. Sharma MC, BakhshiS. Subcutaneous nodules as initial presentation of Burkitt lymphoma in HIV-negative child.JPediatrHematolOncol. 2013 Nov;35(8):e326-8

• Gogia A. Raina V, Gupta R.Disseminated tuberculosis mimicking relapse in hairy cell leukemia.Indian J Cancer. 2013 Oct-Dec;50(4):321.

• Gogia A. Mehta P, Raina V.Cryptococcal meningitis in chronic lymphocytic leukemia.Indian J Cancer. 2013 Oct-Dec;50(4):301.

• Gogia A. Raina V, Gupta R.Massive ascites as an presenting feature of plasma cell leukemia.Indian J Cancer. 2013 Oct-Dec;50(4):301.

• Gogia A. Sharma A, Chopra A, Kumar R Mediastinal granulocytic sarcoma: poor risk AML?.J Indian Med Assoc. 2013 Aug;111(8):562.

• Gajendra S, Gogia A. Tanwar P, Sahoo MK, Bhethanabhotla S, Durgapal P, Gupta R.Synchronous metastatic pulmonary adenocarcinoma with small cell lymphoma.Leuk Lymphoma. 2014 Jul;55(7):1678-80.

• Gogia A. Pushker N, Sen S, Bakhshi S. Avoidance of exenteration in orbital sebaceous gland carcinoma with neoadjuvantchemotherapy.Graefes Arch ClinExpOphthalmol. 2013 Oct;251(10):2479-80. doi: 10.1007/s00417-013-2382-8. Epub 2013 May 25. No abstract available.

• Gogia A. Pathania S, Das P, Gupta YK, Bakhshi S.Methotrexate-induced toxic epidermal necrolysis in a child.Indian J Dermatol. 2013 Mar;58(2):161.

• Gogia A. Sharawat SK, Kumar R, Sarkar C, BakhshiS.Systemicmastocytosis associated with childhood acute myeloid leukemia.JPediatrHematolOncol. 2013 Mar;35(2):163-4.

• Gogia A.Sharma A, Raina V, Kumar L, Vishnubhatla S, Gupta R, Kumar R.Assessment of 285 cases of chronic lymphocytic leukemia seen at single large tertiary center in Northern India.Leuk Lymphoma. 2012 Oct;53(10):1961-5

• Gogia A.Sharma A, Raina V, Gupta R.Priapism as an initial presentation of chronic lymphocytic leukemia.Leuk Lymphoma. 2012 Aug;53(8):1638-9. doi: 10.3109/10428194.2012.656636.

• Mishra J, Chopra A, Gogia A.Kumar R.Seemingly insignificant, but crucial morphological leads in the diagnosis of non-secretory multiple myeloma in an adolescent.Indian J PatholMicrobiol. 2012 Jan-Mar;55(1):130-2

• Gajendra S, Gupta R, Sharma A, Gupta R,Gogia A.Acute myeloid leukaemia with Pseudo-Chediak-Higashi granules and intracytoplasmicvacuoles.Eur J Haematol. 2011 Jun 16. doi: 10.1111/j.1600-0609.2011.01668.

• Gogia A.Thulkar S, Sahoo R, BakhshiS.Intramedullary spinal cord hemorrhage in childhood acute lymphoblastic leukemia following lumbar puncture.Pediatr Blood Cancer. 2011 Feb;56(2):329-30

• Gogia A. Mishra J, Kumar R, BakhshiS.Nonsecretory myeloma in a child.Pediatr Blood Cancer. 2011 Feb;56(2):321-2. doi: 10.1002/pbc.22812

• Kumar L, Ganessan P, Ghosh I, Panda D, Gogia A. MandhaniaS.Autologous blood stem cell transplantation for Hodgkin and non-Hodgkin lymphoma: complications and outcome.Natl Med J India. 2010 Nov-Dec;23(6):330-5.

• Gogia A. BakhshiS.Plasmablastic lymphoma of oral cavity in a HIV-negative child.Pediatr Blood Cancer. 2010 Aug;55(2):390-1.

• Ganesan P, Sharma A, Mohanti BK, Gogia A..Protracted cisplatin-induced vomiting responding to mosapride.Indian J Cancer. 2010 Jan-Mar;47(1):73-4.

• AG Vallonthaiel, S Kaushal, Gogia A. S R. Mathur. Bilateral Myeloid Sarcoma of Breast in a Young Male Occurring after 11 Years of Chronic Myeloid Leukemia Diagnosis: A Unique Pattern of Relapse. The Breast Journal.2016; 22(6), 692-693

• Gogia A. Nath D. T Cell Lymphoma: A Rough Road to Diagnosis. American Journal of Cancer Case Reports. 2015; 3 (3), 177-181

• Gogia A. Mehta P, Pramanik R, Gupta R. Chronic lymphocytic leukemia with massive ascites: An unusual presenting manifestation. South Asian J Cancer. 2014 Oct;3(4):235-6.

• Attili VS, Singh VP, Sundar S, Mehta H, Negi ML, Gogia A. Raju SH, Rai M. Malignantmyelomatous pleural effusion with good response to combination chemotherapy. J Assoc Physicians India. 2007 Aug;55:595-6.

• Gogia A. Aggarwal N, Jayaswal A. Angiosarcoma of spine .Indian Journal of Medical and Paediatric Oncology 2006; 27 (3), 40.

• Mehata H, Gogia A. et al. A case of post bee sting encephalitis. African Journal of Neurological Sciences. 2006;25:69-72

Recently accepoted

• A Mishra, AS Oberoi, S Deo, J Sharma, A.Gogia, DN Sharma, S Mathur, Bilateral Breast Cancer: Clinical Profile and Management Indian Journal of Surgical Oncology 2023 , 1-8

 

POSTER / ORAL PRESENTATION – abstracts

• MB BM, akashkumar, A Batra, V Sharma, B Kataria, A.Gogia, S Mathur,Metformin with neoadjuvant chemotherapy in localized triple negative and HER2neu-positive breast cancer: A prospective phase 2 open label randomised controlled trial (McBETH)....Journal of Clinical Oncology 41 (2023) (16_suppl), TPS631-TPS631.

• R Pramanik, S Vats, S Mitra, SVS Deo, L Kumar, A.Gogia, S Khurana, Assessment of Knowledge and Attitude of Breast and Ovarian Cancer Patients Regarding Hereditary Breast-Ovarian Cancer Syndrome at a Tertiary Cancer Institute: A Cross-Sectional … Indian Journal of Medical and Paediatric Oncology (2023).

• A.Gogia, S Kumar, A Sharma, S Mallick, R Gupta, : IBCL-188 Hairy Cell Leukemia: A Single Center Analysis from India Clinical Lymphoma Myeloma and Leukemia (2023), S449

• R Thakur, S Deo, AS Oberoi, S Bhoriwal, D Sharma, A.Gogia, U Dasgupta, Role of lipidomic signatures in prognostication of breast cancer-A pilot study European Journal of Surgical Oncology 49 (5), 2023 e230

• A Mishra, SVS Deo, A.Gogia, S Mathur, J Sharma, J Josiphen148P Pattern of axillary lymph node involvement and scope of post neoadjuvant chemotherapy sentinel lymph node biopsy among breast cancer patients in developing countriesESMO Open 8 2023 (1)

• A Mishra, SVS Deo, A.Gogia, B Bansal, S Bhoriwal, 176P Awareness & knowledge pertaining to genetic breast cancer in developing countries: A questionnaire based prospective study of 300 patientsESMO Open 8 (1) 2023

• AS Oberoi , SVS Deo , S Bhoriwal , DN Sharma , A.Gogia. , S Mathur et al Lipidomics in breast cancerEuropean Journal of Surgical Oncology 49 (5), 2023 e239

• R Kumar, U Agrawal, S Deo, SR Mathur, A.Gogia,P Tanwar, :- Comprehensive mutation profiling of PIK3CA gene in Indian breast cancer patients European Journal of Cancer 175, S33 (2023)

• A.Gogia, S Kirar, A Sharma, A Agni, S Mallick, R Gupta,ABCL-165 Primary Testicular Diffuse Large B-Cell Lymphoma: Outcome With Uniform Treatment Protocol Clinical Lymphoma Myeloma and Leukemia (2023), S421

• A.Gogia, A Santosh, S Mallick, R Gupta,: ABCL-190 Primary Cutaneous Non-Hodgkin Lymphoma-Leg Type: Long-Term Durable Response With Dose-Adjusted EPOCH-R RegimenClinical Lymphoma Myeloma and Leukemia (2023), S425-S426

• A.GogiaS Kirar, A Sharma, A Agni, S Mallick, R Gupta, POSTER: ABCL-165 Primary Testicular Diffuse Large B-Cell Lymphoma: Outcome With Uniform Treatment Protocol Clinical Lymphoma Myeloma and Leukemia (2023), S200

• A.Gogia, Kirar S, Sharma A, Gupta A, Mallick S,ABCL-167 HIV-Associated Diffuse Large B-Cell Lymphoma: Outcome With Uniform DA-EPOCH-R Protocol Clinical Lymphoma Myeloma and Leukemia (2023), S421.

• A Chaudhary, A Sharma, A.Gogia, PS Malik, A Batra, akashkumar, :Sexual health among cancer patients on active chemotherapy: A cross-sectional study from tertiary care cancer center in India. Journal of Clinical Oncology 41 (2023)(16_suppl), e24224-e24224

• N SG, A.Gogia, R Pramanik, HKR Sagiraju, SVS Deo, DN Sharma, :- Survival outcomes of BRCA1/BRCA2 mutated breast cancers: Study from a tertiary care cancer centre in India.Journal of Clinical Oncology 41 (16_suppl) (2023), e22546-e22546

• A Batra, A Sharma, S Bakhshi, A.Gogia R Pramanik, S Khurana, :- Assessing the feasibility of recording smartphone-based patient-reported outcomes in patients with cancer: A pilot study.Journal of Clinical Oncology 41 (2023)(16_suppl), e13528-e13528

• A.Gogia, N SG, R Pramanik, R Gupta, SVS Deo, S Mathur, D Sharma, :-Prevalence of BRCA1 and BRCA2 mutations in an unselected cohort of Indian women with breast cancer. Journal of Clinical Oncology 41 (2023).(16_suppl), e13004-e13004.

• A.GogiaN SG, S Mathur, SVS Deo, S Ganguly, A Batra, D Sharma, :- Prevalence of low HER2 expression in breast cancer patients: An Indian experience. Journal of Clinical Oncology 41 (2023)(16_suppl), e12543-e12543

• A.Gogia, A Santosh, S Mallick, R Gupta,POSTER: ABCL-190 Primary Cutaneous Non-Hodgkin Lymphoma-Leg Type: Long-Term Durable Response With Dose-Adjusted EPOCH-R RegimenClinical Lymphoma Myeloma and Leukemia (2023), S207

• A.Gogia, S Kumar, A Sharma, S Mallick, R Gupta,POSTER: ABCL-189 The Spectrum of HIV-Associated Hematological Malignancies at a Tertiary Care Centre in North IndiaClinical Lymphoma Myeloma and Leukemia (2023), S200

• A.Gogia, S Kumar, A Sharma, S Mallick, R Gupta, ABCL-189 The Spectrum of HIV-Associated Hematological Malignancies at a Tertiary Care Centre in North India Clinical Lymphoma Myeloma and Leukemia (2023), S425

• S Ganguly, A.Gogia, Tumor-infiltrating lymphocyte therapy versus ipilimumab in advanced melanomaCancer Research, Statistics, and Treatment 6 (1) (2023), 173-174.

• AP Santhosh, A.Gogia, Rezvilutamide in metastatic, hormone-sensitive prostate cancerCancer Research, Statistics, and Treatment 6 (1) (2023), 172-173.Kumar R, Srivastava A, Agrawal U, Deo SV, Mathur SR, A.Gogia, Tanwar P. Evaluation of mutation profile of oncogenic signalling pathway in breast cancer among Indian population. Cancer Research. 2022 Jun 15;82(12_Supplement):2277.

• A.Gogia, S Nair, S Kumar, A Sharma, A Biswas, S Mallik, R GuptaPoster : ABCL-200 Primary and Secondary Extranodal Diffuse Large B-Cell Lymphoma: A Single-Center Survey from India Clinical Lymphoma, Myeloma and Leukemia (2022).S167

• I Gupta, MR Lone, P Ramteke, A.Gogia, A Upadhyay, S Mallick, :Poster: ABCL-523 Immunohistochemical (IHC) Expression of Epigenetic Regulators (EZH-2 and H3K27) as well as Cell Cycle Regulators (P16, P53 and RB) in Patients Diagnosed With … Clinical Lymphoma, Myeloma and Leukemia (2022), S170

• R Kumar, A Srivastava, U Agrawal, SVS Deo, SR Mathur, A.Gogia... Evaluation of mutation profile of oncogenic signalling pathway in breast cancer among Indian population Cancer Research 82 (2022) (12_Supplement), 2277-2277

• B Chaudhary, A Mahalik, P Kumar, M Tripathi, A.Gogia, R Kumar, CS BalInitial experience of fully automated radiosynthesis and biodistribution of ¹⁸F-FESIndian Journal of Nuclear Medicine 37 (2022)(5, suppl. 1), S47-S48.

• Deo SVS, Chhebbi M, Mishra A, Sharma J, Gogia. A, Pramanik R:- A Review of Surgical Perspectives of Breast Cancer Genetics and Risk-Reducing Surgery Indian Journal of Surgery 84 (Suppl 3), 605-610 (2022)

• I Gupta, MR Lone, P Ramteke, A.Gogia Upadhyay, S Mallick Poster: ABCL-523 Immunohistochemical (IHC) Expression of Epigenetic Regulators (EZH-2 and H3K27) as well as Cell Cycle Regulators (P16, P53 and RB) Clinical Lymphoma, Myeloma and Leukemia 2022, S170

• I Gupta, MR Lone, P Ramteke, A.Gogia, A Upadhyay, S Mallick, ABCL-523 Immunohistochemical (IHC) Expression of Epigenetic Regulators (EZH-2 and H3K27) as well as Cell Cycle Regulators (P16, P53 and RBClinical Lymphoma Myeloma and Leukemia 2022, S382

• A.Gogia, R Gupta, L Kumar, A Sharma, L Rani, S MallickIBCL-429 Prevalence of B-Cell Chronic Lymphoproliferative Disorders at a Large Tertiary Care Center in IndiaClinical Lymphoma Myeloma and Leukemia 2022, S392

• Bharath BG, A.Gogia. Smart start: It really is SMART!Cancer Research, Statistics, and Treatment 5 (4), 795-796 (2022)

• Jain S , Mandal T,Ramteke P, Sharma MC, A. Gogia, M Aggarwal, ...Poster: TCL-306 Application of the Proposed Immunohistochemistry Algorithm for the Prognostication of GATA3 and TBX21 Subtypes of Peripheral T-Cell Lymphoma, Not Otherwise …Clinical Lymphoma, Myeloma and Leukemia (2022), S176

• J Ghosh, C Das, A.Gogia, G Biswas, C Desai, S Rajpurohit, P Mehta, ...EP216/# 881 Safety and tolerability of olaparib in Indian patients with ovarian cancer: the prospective, single-arm, phase 4 soli trial International Journal of Gynecologic Cancer (2022) 32 (Suppl 3)

• Gupta A, A.Gogia, Sagiraju HK, Deo SV, Gupta R, Mathur S, Sharma D. A real-world experience of TCH (docetaxel/carboplatin/trastuzumab) regimen in early, locally advanced and oligometastatic HER2 positive breast cancer from tertiary care center in North India. J Clin Oncol 2022;40:e12505-e12505 .

• A.Gogia, Gupta A, Deo SV, Sharma D, Mathur S. Safety, efficacy and survival outcome of Ado-trastuzumab emtansine (T-DM1) in patients with metastatic HER2-positive breast cancer: An Indian experience. J Clin Oncol 2022;40:e13008-e13008.

• Sharma RK, A.Gogia, Sagiraju HK, Deo SS, Sharma D, Mathur S. Impact of capecitabine maintenance on survival outcomes in triple-negative breast cancer patients not attaining pathological complete response following neoadjuvant chemotherapy: Real-world data from a tertiary care center from India. J Clin Oncol 2022;40:e12593-e12593.

• Batra A, kumar A, Pramanik R, Khurana S, Pushpam D, Bakhshi S, Sharma A, A.Gogia, Malik PS. Physical and psychological symptom burden in patients newly diagnosed with solid organ cancers in a tertiary care centre in India. J Clin Oncol 2022;40:e24081-e24081.

• Sagiraju HK, A.Gogia, Sharma RK, Deo SV, Sharma D, Gupta R, Mathur S. Association of pre-treatment hemoglobin levels with survival outcomes among Indian women with triple negative breast cancer. J Clin Oncol 2022;40:e12549-e12549

• Gupta A, A.Gogia, Sagiraju HK, Deo SV, Sharma D, Mathur S, Gupta R. Outcomes of neoadjuvant combination chemotherapy with and without targeted therapy in HER2-positive breast cancer: A real-world experience from tertiary care center in North India. J Clin Oncol 2022;40:e12601-e12601 .

• A.Gogia, Sharma A, Gupta R, Rani L, Mallick S. Safety and efficacy of Ibrutinib in Indian patients with chronic lymphocytic leukemia. J Clin Oncol 2022;40:e19585-e19585

• Das N, Gupta R, Dahiya M, Rai S, Singh S, Sahoo RK, A.Gogia, Sharma A, Kumar L. MM-359: Pattern-Based Identification of Normal and Aberrant Plasma Cell Compartment across a Spectrum of Plasma Cell Proliferative Disorders Using Multiparametric Flow Cytometry. Clinical Lymphoma Myeloma and Leukemia. 2021 Sep 1;21:S438.

• S Jain, A Goswami, T Mandal, MR Lone, P Ramteke, MC Sharma A.Gogia....Poster: TCL-239: Clinical, Pathological, and Prognostic Implications of RHOAG17V Mutation in Peripheral T-Cell Lymphomas Clinical Lymphoma Myeloma and Leukemia 2021, S248

• DN Sharma, SVS Deo, S Bhoriwal, Y Izzuddeen, A Binjola, A. Gogia :-MSPP04 Presentation Time: 4: 30 PM: Interstitial Brachytherapy Based Accelerated Partial Breast Irradiation After Oncoplastic Breast Conserving SurgeryBrachytherapy 2021 (6), S36

• N Das, R Gupta, M Dahiya, S Rai, S Singh, RK Sahoo, A.Gogia, A Sharma, ... MM-359: Pattern-Based Identification of Normal and Aberrant Plasma Cell Compartment across a Spectrum of Plasma Cell Proliferative Disorders Using Multiparametric Flow Cytometry Clinical Lymphoma Myeloma and Leukemia 2021, S438

• A.Gogia, S Chellapuram, A Sharma, S Mallick, R Gupta, ABCL-064:“DA-EPOCH+/-R” Protocol in High-Grade Lymphoma: An AnalysisClinical Lymphoma Myeloma and Leukemia 2021 , S379-S380

• R Gupta, N Das, M Dahiya, S Rai, S Singh, VK Prajapati, A.Gogia...MM-329: Evaluation of Immunophenotype of the Non-Neoplastic Plasma Cell Compartment and Post-Therapy Immunomodulation to Understand Nuances in MRD Assessment of Multiple …Clinical Lymphoma Myeloma and Leukemia 2021, S436-S437

• P Ramteke, S Jain, S Meena, T Mandal, P Das, R Yadav, MC Sharma, A. Gogia:- ...Poster: ABCL-321: Clinicopathological Profile of Gastrointestinal Lymphoma Diagnosed Over a Period of 6-Years: A Tertiary Care Center ExperienceClinical Lymphoma Myeloma and Leukemia 2021, S242

• A. Gogia, Kumar L, Sharma A, Mallick S, Gupta R, Rani L. CLL-069: Incidence of Second Cancer in Patients with Chronic Lymphocytic Leukemia: The Indian Scenario. Clinical Lymphoma, Myeloma and Leukemia. 2021 Sep 1;21:S316-7.

• Jain S, Goswami A, Mandal T, Lone MR, Ramteke P, Sharma MC, A. Gogia , Sharma A, Aggarwal M, Sahoo R, Bakhshi S. TCL-239: Clinical, Pathological, and Prognostic Implications of RHOAG17V Mutation in Peripheral T-Cell Lymphomas. Clinical Lymphoma, Myeloma and Leukemia. 2021 Sep 1;21:S413-4.

• Sharma RK, A. Gogia Deo SV, Sharma D, Mathur S, Sagiraju HK. Does pathological complete remission after neoadjuvant chemotherapy translate to longer relapse-free survival in patients with triple-negative breast cancer in the Indian population? J Clin Oncol. 2021;39:e12618-e12618.

• Sagiraju HK, A. Gogia Sharma D, Deo SV, Mathur S. Survival outcomes of breast cancer patients with brain metastases: Single center experience from Northern India. J Clin Oncol. 2021 39:15_suppl, e13003-e13003

• A. Gogia Arora S, Choudhary P, Kumar R, Thulkar S, Deo SV, Sharma D, Bhatnagar S. Real-world Indian scenario of CDK4/6 inhibitors (palbociclib and ribociclib) with endocrine therapy in upfront hormone positive metastatic breast cancer. J Clin Oncol 2021 39:15_suppl, e13028-e13028.

• A. Gogia, Arora S, Deo SV, Mathur S, Sharma D. Efficacy and safety of neoadjuvantdocetaxel, carboplatin, trastuzumab, and pertuzumab (TCH-P) in HER2-positive breast cancer: An Indian experience. J Clin Oncol. 2021 39:15_suppl, e12619-e12619 Sharma RK, A.GOGIAGupta R, Deo SV, Sharma D, Mathur S, Sagiraju HK. Impact of pre-treatment derived neutrophil-lymphocyte-ratio on outcomes in patients with triple- negative breast cancer. J Clin Oncol 2021 39:15_suppl, e12556-e12556.

• Atul Batra, Akhil P. Santosh, Raja Pramanik, A. Gogia, R. M. Pandey, akashkumar, Atul SharmaRandomized double-blind, placebo-controlled study of topical diclofenac in prevention of hand-foot syndrome in patients receiving capecitabine. (ASCO 2021) J Clin Oncol 39, 2021 (suppl 15; abstr TPS12135)

• Rakesh Kumar Sharma, A. Gogia, SVS Deo, Dayanand Sharma, Sandeep Mathur, Hari Krishna Raju Sagiraju;Impact of pre-treatment derived neutrophil-lymphocyte-ratio on outcomes in patients with triple-negative breast cancer. J Clin Oncol 39, 2021 (suppl 15; abstr e13010)

• K Raghuram, SVS Deo, A. Gogia, S Thulkar, E Dhamija, DN Sharma, Analysis of surgical and oncological outcomes of breast conservation surgery following neo adjuvant chemotherapy in locally advanced breast cancer. European Journal of Surgical Oncology 46 2021(6), e31

• SC Nair, A. Gogia, L Kumar, A Sharma, A Biswas, S Mallick :-Clinicopathological features and outcome of diffuse large B-cell lymphoma patients treated in a resource-limited setting.Journal of Clinical Oncology 38 (15_suppl), e20062-e20062

• A. Gogia, S Nair, A Sharma, L Kumar, S Mallick, A Biswas, R Gupta Non-Hodgkin lymphoma: The Indian scene. Journal of Clinical Oncology 38 (15_suppl), e20063-e20063

• A. Gogia, S Deo, D Sharma, S Mathur. Breast cancer: The Indian scenario.Journal of Clinical Oncology 38 (15_suppl), e12567-e12567

• SC Nair, A. Gogia, L Kumar, A Sharma, A Biswas, S Mallick Clinicopathologic features and outcome of extra-nodal diffuse large B-cell lymphoma: An institutional experience from North India.Journal of Clinical Oncology 38 (15_suppl), e20079-e20079

• P Choudhary, A. Gogia, S Deo, S Mathur, D Sharma. Neoadjuvant chemotherapy in locally advanced breast cancer: Clinicopathological characteristics and correlation with pathological complete response.Journal of Clinical Oncology 38 (15_suppl), e12658-e12658

• R Gupta, L Rani, G Kaur, S Khan, A. Gogia ,A Gupta, A Sharma, L KumarmiR-223 and miR-551a as gene signatures of aggressive chronic lymphocytic leukemia. Leukemia& Lymphoma 61, 206-207

• S Mathur, A Johnson, SVS Deo, A. Gogia, S Kahol, D Jain, V IyerPDL1 Expression and Tumour Infiltrating Lymphocytes in Triple-Negative Breast Cancer and its Correlation with Clinicopathological Features and Response to ChemotherapyLaboratory Investigation 100 (Suppl 1), 208-209

• H Natarajan, L Kumar, S Bakhshi, A Sharma, T Velpandian, M Kabra, A. Gogia Imatinib induced toxicity and its influence on cytogenetic and molecular response in newly diagnosed patients with chronic myeloid leukemia Annals of Oncology 201930 (Supplement_9), mdz427. 004

• A. Gogia L Kumar, A Sharma, R Gupta, L Rani. Incidence and outcome of chronic lymphocytic leukemia with deletion 17p: An Indian experience; challenges and opportunities. Annals of Oncology 30 (Supplement_5), mdz269. 055

• N Das, A Malhotra, R Gupta, S Rai, SK Gupta, RK Sahoo, A. GogiaCD123 is an Important Predictor of Post Induction Response and Early Treatment Outcome in Acute Lymphoblastic Leukemia. Clinical Lymphoma, Myeloma and Leukemia 19, S197

• S Mallick, A Panda, MR Lone, A Goswami, P Ramteke, MC Sharma, A. GogiaClinicopathologicalProfileof Primary Double Expressor Lymphoma. Clinical Lymphoma, Myeloma and Leukemia 19, S257

• N Das, A Malhotra, R Gupta, S Rai, S Singh, RK Sahoo, A. Gogia.Role of CD123 as Determinant of Minimal Residual Disease in Acute Myeloid Leukemia. Clinical Lymphoma, Myeloma and Leukemia 19, S235

• A. Gogia, R Gupta, A Sharma, L Kumar, V Raina, L Rani. Chronic lymphocytic leukemia: An Indian experience. Journal of Clinical Oncology 37 (15_suppl), e19007-e19007 2019

• KR Soti, L Kumar, R Saxena, S Bakhshi, A. Gogia, PS Malik, R Sahoo. Characteristics and outcomes of Philadelphia chromosome-negative myeloproliferative neoplasm in a tertiary institute in India: An ambispective study. Journal of Clinical Oncology 37 (15_suppl), e18553-e185532019

• M Sharma, A. Gogia SVS Deo, NK Shukla, S Thulkar, R Kumar, D SharmaProfile of metastatic breast carcinoma: Single center experience from a developing country. Journal of Clinical Oncology 36 (15_suppl), e13102-e13102……2018

• M Sharma, A. Gogia SVS Deo, NK Shukla, D Sharma, S Thulkar, R KumarEstrogen receptor (ER), progesterone receptor (PR) and Her2neu receptor expresssion: Change from baseline to first metastasis in breast cancer—Single center experience from … Journal of Clinical Oncology 36 (15_suppl), e13095-e1309, 2018

• SK Paikaray, A. Gogia L Kumar, A Sharma, A Biswas, MC SharmaA phase III open label randomized study to compare the efficacy of lenalidomide-rituximab vs bendamustine-rituximab in treatment naive follicular lymphoma. Journal of Clinical Oncology 36 (15_suppl), e19552-e19552…….2018

• A Biswas, L Kashyap, N Adhikari, A. Gogia, R Sahoo, A Sharma. Secondary central nervous system lymphoma clinical experience from a regional cancer centre in India. Radiotherapy and Oncology 127, S692…2018

• L Rani, M Dahiya, N Mathur, R Gupta, A. Gogia, L Kumar, A Sharma.Detection of genetic aberrations in CLL using multiplex ligation-dependent probe amplification (MLPA).Leukemia & Lymphoma 58, 176-177..2017

• SVS Deo, NK Shukla, A. GogiaBilateral Breast Cancer-Incidence, Clinical Spectrum And Challenges In The Management.. Journal of Cancer Research & Therapeutics 13. 2017

• SVS Deo, NK Shukla, A. Gogia, Criteria For Pathological Complete Response (Pcr) Cr And Its Impact On Relapse Rates In Breast Cancer Patients Undergoing Neo-Adjuvant Chemotherapy- Journal of Cancer Research & Therapeutics 13. 2017

• L Rani, R Gupta, N Mathur, K Singh, A. Gogia, D Sundar, L Kumar,Elucidation of miRNAs associated with disease progression and response in chronic lymphocytic leukemia, et.al. LEUKEMIA & LYMPHOMA 58, 173-174….2017

• A Jakhetiya, SS Deo, NK Shukla, A. Gogia D Sharma, D Muduly, S Mathur ,Patterns of Loco-Regional Relapse in Curatively Treated Locally Advanced Breast Cancer (LABC) Patients: A Single Centre Retrospective Study. et.al. Annals Of Surgical Oncology 24, S50-S50…2017

• VG Gupta, A. GogiaP Mehta, L Kumar, A Sharma, S Bakhshi, S Thulkar.Early stage natural killer/T cell lymphoma with local tumor invasiveness treated with a uniform SMILE protocol: An institutional study from India. Annals of Oncology 27 (suppl_9)..2016

• S Bhoriwal, S Deo, R Kumar, NK Shukla, S Thulkar, A. Gogia DN Sharma,A prospective study comparing conventional investigation and PET-CT scan for staging in locally advanced breast carcinoma. et.al. European journal of Surgical Oncology Volume 42,Issue 42, Issue 9, Pages S138

• CK Das, L Kumar, A. Gogia R Kaushal.Bone marrow involvement in mantle cell lymphoma: An immunophenotyping analysis with clinicopathologic correlation from a tertiary care center in North India.European Journal of Surgical Oncology 42 (9), S138..2016

• S Taywade, R Kumar, A Behera, N Damle, M Tripathi, A. Gogia CS Bal.Role of 18F-FDG PET/CT in the management of patients with primary breast lymphoma.Journal of Clinical Oncology 34 (15_suppl), e19073-e19073

• L Kumar, RR Boya, R Pai, B Sainath, RK Sahoo, PS Malik, A Mookerjee, A. GogiaAutologous stem cell Transplantation (ASCT) for Multiple Myeloma (MM): Predictors of long term outcome. Journal of Nuclear Medicine 57 (supplement 2), 1623-1623…2016

• A Singh, S Purkait, A. Gogia, S Mallick.Non-Hodgkin lymphoma unclassifiable between diffuse large B-cell lymphoma and Burkitt lymphoma. Clinical Lymphoma, Myeloma and Leukemia 15, e146-e147

• R Gupta, L Rani, N Mathur, A. Gogia D Sundar, A Sharma, L Kumar. Impact of DNA methylation and gene expression profile on treatment initiation and treatment free survival in early stage CLL.Clinical Lymphoma, Myeloma and Leukemia 15, e145-e146

• RR Boya, S Bakhshi, A. Gogia RK Sahoo, L Kumar. Prediction of poor mobilization of Peripheral Blood Stem Cells (PBSC) with G-CSF alone, in multiple myeloma (MM) patients undergoing autologous transplantation.Clinical Lymphoma, Myeloma and Leukemia 15, 171-72

• P Mehta, V Raina, L Kumar, A Sharma, S Bakhshi, A. Gogia T Tvsvgk.Nasal NK-T cell lymphoma: 10-year experience of a single institute in India.Journal of Clinical Oncology 32 (15_suppl), 19536

• S Mallick, MR Lone, P Ramteke, S Purokait, A. Gogia. Clinico‐Pathological Profile And Cmyc Immunoreactivity Of Alk Positive Large B Cell Lymphoma: Report Of Nine Cases Hematological Oncology Volume 35, Issue S2,Page 395-6

• Ritu Gupta, Lata Rani, NitinMathur, A. Gogia ADuraiSundar, Atul Sharma, Lalit Kumar.Impact of DNA methylation and gene expression profile on treatment initiation and treatment free survival in early stage CLL. Journal of Clinical Oncology 33 (15_suppl), e22073- e22073

• SK Bhoriwal, SVS Deo, NK Shukla, P Garg, R Kumar, A. Gogia DN Sharma, S Thulkar, S Mathur. 18FDG PET-CT–SUV correlation with molecular subtypes in locally advanced/recurrent breast carcinoma Hematological Oncology Volume 35, Issue S2, Pages, 395-396

• Pankaj Kumar Garg, SV SuryanarayanaDeo, Rakesh Kumar, Nootan Kumar Shukla, Sanjay Thulkar, A. Gogia , Dayanand Sharma, Sandeep R Mathur. Role of FDG PET–CT (Positron Emission Tomography and Computed Tomography) scan in the staging of locally advanced/recurrent breast cancer as a single modality.. Journal of Clinical Oncology Volume 33 e11508Publisher American Society of Clinical Oncology

• CK Das, A Garg, A. Gogia, 533P Docetaxel induced cutaneous toxicity in breast cancer patients.(2016) (Annals of Oncology Volume 27Issuesuppl_9) …

• Prashant Mehta, VinodRaina, Lalit Kumar, Atul Sharma, Sameer Bakhshi, A. Gogia, TilakTvsvgk, BivasBiswas, SiddharthSahai, Surendra Pal Chaudhary, Vijay Murugan, Mehar C Sharma, SandeepMathur, Sanjay Thulkar. Nasal NK-T cell lymphoma: 10-year experience of a single institute in India.Journal of Clinical Oncology Volume 32Issue 15_suppl Pages e19536 Publisher American Society of Clinical Oncology

• C.K. Das, A. Gogia, N.K. ShuklaS. DeoS. MathurD. SharmaPrognostic significance of the derived neutrophil lymphocyte ratio in metastatic breast cancer: A tertiary cancer care center analysis from India. Annals of Oncology, Volume 27, Issue suppl_9, 1 December 2016, mdw577.005,

• Natarajan H, Lalit Kumar, Sameer Bakhshi, Atul Sharma, Madhulika K, Velpandian T, A. Gogia, ShivaramShastri, Yogendra Kumar Gupta. Influence of MDR1 and CYP3A5 genetic polymorphisms on trough levels and therapeutic response of imatinib in patients with chronic myeloid leukemia.Cancer Research Volume76 Issue14 Supplement Pages2040-2040 Publisher American Association for Cancer Research

• Reddy R, Sharma A, Bakhshi S, A. Gogia, Sahoo R, Yadav CP, Kumar L. Comparison of three leukapharesis machines for harvest of stem cells for autologous transplantation: A prospective study.Journal Of Clinical Oncology 34(15_Suppl) 8024

• H Natarajan, L Kumar, S Bakhshi, A Sharma, T Velpandian, A. Gogia, K Gupta. Imatinib trough levels: A potential biomarker to predict cytogenetic and molecular response in newly diagnosed patients with chronic myeloid leukemia. Annals of Oncology Volume 27 Issue suppl_9 Page 586

• P Mehta, L Kumar, V Raina, A Sharma, S Bakhshi, A. Gogia RK Sahoo, S Pabbi, A Chopra, R Kumar high dose (18 g/m) versus low dose (12 g/m) cytosine arabinoside as consolidation for acute myeloid leukemia. Annals of Oncology 26,85

• CK Das, L Kumar, SR Mallick, A. GogiaPrognostic significance of monocyte-lymphocyte ratio in mantle cell lymphoma.Annals of Oncology.2015; Volume 26 Issue suppl_9

• Ritu Gupta, Lata Rani, NitinMathur, A. Gogia, SreenivasVishnubhatla, Lalit Kumar, Atul Sharma, DivyaDubey, PunitKaur. Analysis of IGHV-DJ gene rearrangement and B-cell receptor stereotypes in chronic lymphocytic leukemia: an Indian study. Leukemia & Lymphoma.2015; Volume 56 Pages 124-125

• R Upadhyay, DN Sharma, AK Gandhi, K Haresh, S Deo, A. GogiaRole of radiation therapy and its impact on survival of male breast cancer patients: experience from a tertiary cancer center. International Journal of radiation Oncology.biology.Physics.2016; 96(2)E 29

• R Reddy, S Bakhshi, A Sharma, R Sahoo, A. Gogia PS Malik, S Iqbal, Poor mobilization of peipheral blood stem cells (PBSC) in patients undergoing autologous stem cell transplantation (ASCT): A prospective study.ClinicalLymphoma, Myeloma and Leukemia.2015; 15, e 171

• S Gajendra, A Chopra, S Kumar, A.Gogia J Chandramohan, S Bakhshi.Immunophenotypic analysis of T-lineage acute lymphoblastic leukemia. CD5 matters.... International Journal of Radiation Oncology.2016;• Biology• Physics 96 (2), E29

• L Kumar, P Ganess, A. Gogia I Ghosh, R Hariprasad. High Dose Chemotherapy With Autologous Stem Cell Transplantation For Multiple Myeloma: What Predicts The Outcome? Journal of Clinical Oncology.2015; 33 (15_suppl), e18013-e18013

• A. Gogia,V Raina , Sharma MC .Survival outcome of patient with primary gastric diffuse large B-cell lymphoma: An Institutional experience from developing country.Annals of Oncology 2014 Volume26 Issue suppl 4

• A. Gogia, V Raina, A Sharma, L Kumar, R Gupta, MC Sharma Incidence of second cancer in patients with chronic lymphocytic leukemia: 13 years experience from single institute.European Journal Of Cancer.2013; 49, S846-S846

• A. Gogia, V Raina, A Sharma, L Kumar, R Gupta, S Gajendra, Significance of smudge cell on blood smear in chronic lymphocytic leukemia patients: A prospective single institutional study from India.European Journal Of Cancer.2013; 49, S207-S208

• Gupta A, N Das, M Dahiya, S Rai, S Singh, VK Prajapati, Gogia A. ... Poster: MM-329: Evaluation of Immunophenotype of the Non-Neoplastic Plasma Cell Compartment and Post-Therapy Immunomodulation to Understand Nuances in MRD Assessment of …Clinical Lymphoma Myeloma and Leukemia (2021), S256

• N Das, Gupta A, M Dahiya, S Rai, S Singh, VK Prajapati, RK Sahoo, Gogia A. :-...Poster: MM-359: Pattern-Based Identification of Normal and Aberrant Plasma Cell Compartment across a Spectrum of Plasma Cell Proliferative Disorders Using Multiparametric Flow …Clinical Lymphoma Myeloma and Leukemia (2021), S256

• Mansouri L, Thorvaldsdottir B, Sutton LA, Meggendorfer M, Nadeu F, BrieghelC,Parker H, Laidou S, Moia R, Rossi D, Catherwood M, A.Gogia Different PrognosticImpact of Recurrent Gene Mutations in IGHV-Mutated and IGHV-Unmutated ChronicLymphocytic Leukemia: A Retrospective, Multi-Center Cohort Study By Eric, theEuropean Research Initiative on CLL, in Harmony. Blood. 2021 Nov 23;138:2617.

• A.Gogia, A. Sharma, V. Raina, L. Kumar, R. Kumar, R. Gupta.Clinico-hematological characteristics and outcome assessment of patients with chronic lymphocytic leukemia: A single-institution study of 285 cases.DOI: 10.1200/jco.2011.29.15_suppl.6584 Journal of Clinical Oncology 29, no. 15_suppl (May 2011) 6584-6584

• A. Gogia, Vinod Raina, Atul Sharma, Lalit Kumar, Mehar C Sharma, Ritu Gupta, Prasenjit Das.Clinical features and outcome of follicular lymphoma: 17 years experience from All-India Institute of Medical Sciences (AIIMS), New Delhi, India.Journal of Clinical Oncology Volume31 Issue15_suppl Pages e19524-e19524 American Society of Clinical Oncology 2012

• A. Gogia,V Raina, BK Mohanti, SVS Deo, NK Shukla, V Sreeniwas.Clinical significance of triple negativity in young breast cancer patients (<= 35 years): A single-institute study from India.European Journal Of Cancer 49, S315-S315 2013

• A. Gogia, V Raina, B Mohanti, S Deo, N Shukla Pattern and Survival of Lung Metastasis In Young Breast Cancer Patients: A Single Centre Experience Publication date2013/5/1. Journal Lung Cancer, Volume80,PagesS41, DBT -Travel Grant,Wclc, Sydney, Australia,2014

• A. Gogia,V Raina, SVS Deo, BK Mohanti, NK Shukla, S Venkat. An overview of very young breast cancer patients. The Breast, Volume21, PagesS15,SIOP-Travel Scholarship,Dublin 2018

• A. Gogia V Raina, SVS Deo, BK Mohanti, NK Shukla. Profile Of Male Breast Cancer: Single Institution Study Of 76 Patients from Northern India. Annals Of Oncology, Volume23, Pages110-110, young investigator award,Saintgallen Breast Cancer Conferance 2013.

• A. Gogia, A Sharma, V Raina, L Kumar, R Gupta, R Kumar. An Overview Of Young Chronic Lymphocytic Leukemia Patients: A Single Centre Experience Of 117 Cases From Northern India Annals Of Oncology, Volume 23, Pages 358-358, ICMR-TRAVEL GRANT,ESMO-2013,Amsterdam.

• S Roy, A Biswas, A Binjola, M Tripathi, R Kumar, S Bakhshi, R Sahoo, A. Gogia. Early Clinical Outcome, Acute Toxicity Profile And Health Related Quality Of Life After Chemo-Immunotherapy And Involved Site Radiotherapy (ISRT) In Early Nodal DLBCL-Results ..,International Journal Of Radiation Oncology, Biology, Physics.2020; 108 (3), S156-S157

• S Jain, S Mallick, P Ramteke, A. Gogia M Agarwal, J Dass, R Yadav. Pandora Box Of Lymphomas In Spleen. ...Hematology Reports.2020; 12 (s1)

• S Jain, A Goswami, P Ramteke, Mc Sharma, A. Gogia, A Sharma. Tcl-362: Clinicopathological Profile Of Peripheral T-Cell Lymphoma-Nos And Angioimmunoblastic T-Cell Lymphomas., ...Clinical Lymphoma, Myeloma And Leukemia.2020; 20, S256-S257

• Ck Das, A. Gogia, L Kumar, A Sharma, S Thulkar, I Xess, K Madan. Evaluation Of Pulmonary Infiltrate In Febrile Neutropenic Patients Of Hematologic Malignancies. Indian Journal Of Medical And Paediatric Oncology.2019; 40 (03), 386-390

• R Pramanik, H Kancharla, S Bakhshi, A Sharma, A. Gogia, P Malik.Engraftment Syndrome: A Retrospective analysis of the experience at atertiary care Institute,Clinical Hematology International.2019; 1 (2), 114

• M Sharma, A. Gogia, Svs Deo, S Thulkar, RkPhulia, Ps Malik, S Mathur. Prognostic And Predictive Factors of Outcome In Metastatic Breast Cancer In India: Experience From A Dedicated Breast Cancer Clinic Of A Tertiary Health Care Center. The Breast.2019; 44, S61

• A. Gogia, V Raina, S Deo, D Sharma, S Mathur. Survival Outcome Of Pregnancy Associated Breast Cancer In Resource Limited Country: An Analysis. The Breast.2019; 44, S64

• A. Gogia, S Deo, S Mathur, D Sharma, R Gupta. Predictive Significance Of Derived Neutrophil To Lymphocyte Ratio With Neo-Adjuvant Chemotherapy In Triple Negative Breast Cancer: A Single Center Analysis. The Breast.2019; 44, S26

• A. Gogia, V Raina, S Deo, N Shukla, B Mohanti, D Sharma, S Mathur. Neoadjuvant Chemotherapy For Young (</= 35 Years) Locally Advanced Breast Cancer Patients: Association Of Pathological Complete Response With Survival. An Institutional … The Breast. 2019; 44, S128

• M Sharma, A. Gogia Svs Deo, S Thulkar, RkPhulia, Ps Malik, S Mathur. Oligo-Metastatic Breast Cancer: Real World Scenario From A Single Center In India. The Breast. 2019; 44, S60

• R Singh, S Kumar, A. Gogia, D Sharma, S Deo. Impact Of Tumor Size On Prediction Of Pathological Complete Response After Neoadjuvant Chemotherapy In Breast Cancer. The Breast. 2019; 44, S70-S71

• R Singh, S Bhoriwal, A. Gogia, D Sharma, S Deo. Routine Cavity Shave During Breast Conservation Surgery Is A Good Alternative To Frozen Sections. The Breast. 2019; 44, S110-S111

• A Biswas, N Adhikari, A. Gogia, R Sahoo, A Garg, M Sharma, S Bhasker. High Dose Methotrexate Based Chemotherapy And Response Adapted Whole Brain Radiation Therapy In Primary Cns Lymphoma...International Journal Of Radiation Oncology, Biology, Physics. 2018; 102 (3), S192

• N Adhikari, A Biswas, A. Gogia, A Phase II Trial Of Response Adapted Whole Brain Radiotherapy After High Dose Methotrexate Based Chemotherapy In Patients With Newly Diagnosed Primary Central Nervous System … Annals Of Oncology. 2018; 29, Ix22

• R Sahoo, M Patekar, N Adhikari, A Biswas, V Raina, L Kumar, A Sharma, A. Gogia, .Primary Central Nervous System Lymphoma In India: A 17-Year Experience From Aiims. ...Clinical Lymphoma, Myeloma And Leukemia. 2018; 18, S286

• S Mallick, Mr Lone, P Ramteke, S Purokait, A. Gogia, A Batra, S Bakhshi. Clinico‐Pathological Profile AndCmyc Immunoreactivity Of Alk Positive Large B Cell Lymphoma: Report Of Nine Cases. ...Hematological Oncology. 2017; 35, 395-396

• V Ramalingam, S Hari, Sb Paul, S Thulkar, S Vyas, A. Gogia, Svs Deo. Assessment Of Response To Neo-Adjuvant Chemotherapy In Breast Carcinoma Using Shear Wave Elastography., ...European Congress Of Radiology-2017; Ecr 2017

• Ck Das, A. Gogia, Nk Shukla, S Deo, S Mathur, D Sharma. 121p Prognostic Significance Of The Derived Neutrophil Lymphocyte Ratio In Metastatic Breast Cancer: A Tertiary Cancer Care Center Analysis From India. Annals Of Oncology. 2016; 27, Ix36

• A. Gogia, V Raina. An Update Analysis Of Rituximab Based Chemotherapy In Chronic Lymphocytic Leukaemia Patients: An Indian Scenario. Haematologica. 2014; 99, 585-585

• A. Gogia, V Raina, A Sharma, L Kumar, R Gupta, S Vishnubhatla. Smudge Cells On Routine Blood Smear Predict Clinical Outcome In Chronic Lymphocytic Leukemia: An Institutional Study., ...Leukemia& Lymphoma. 2013; 54, 5-6

• A. Gogia, V Raina, S Deo, B Mohanti, N Shukla. An Overview of Male Breast Cancer: 17 Years experience From A Single Centre. Breast. 2013; 22, S47-S47

• R Upadhyay, DN Sharma, AK Gandhi, K Haresh, S Deo, A. Gogia, .Role of radiation therapy and its impact on survival of male breast cancer patients: experience from a tertiary cancer center. …International Journal of Radiation Oncology, Biology, Physics. 2016; 96 (2), E29

• N Harivenkatesh,L Kumar, S Bakshi, A Sharma, M Kabra, T Velpandian, A. Gogia, .Influence of MDR1 and CYP3A5 genetic polymorphisms on trough levels and therapeutic response of imatinib in patients with chronic myeloid leukemia. - Cancer Research. 2016; 76 (14 Supplement), 2040-2040

• A. Gogia,V Raina, A Sharma, L Kumar. Safety and efficacy of rituximab based chemotherapy in chronic lymphocytic leukaemia patients: A single centre experience. European Journal of Cancer. 2013; 49, S844-S845

• H Imran, T Pranay, S. V. S. Deo, A. Gogia,A study of PIK3CA gene mutation and its association with hormone receptor positive and HER2 receptor negative in breast cancer patients". Conference Paper. October 2017. 1st Annual Indian Breast Cancer Conference

 

BOOK CHAPTERS (5)

• Hormone-dependent Malignancies in Elderly: Endometrium, Breast and Prostate, Text book of Geriatric Medicine 2015

• Role of Autologous Transplant in hematological Malignancies, Recent Advance in Hematology 2016

• Basics of Cancer Biology and Therapy: Update in Onco-Anaesthesia 2019

• Applied Aspects of Systemic Therapy in Breast Oncoplasty and Reconstruction Breast Oncoplasty and Reconstruction: Principles and Practice 2023

• Arora S, Gogia A. Tumour Lysis Syndrome. In: Kumar, V., Gupta, N., Mishra, S.(eds) Onco-critical Care. Springer, Singapore. (2022)

  

 

Photo gallery ( International  Fellowship)

Article in India Today Magazine ( Nov 21, 2016)

 

Photo gallery ( FREE MEDICAL CAMP AT LEH AND DHARAMSHALA)

 

Photo gallery (FREE MEDICAL CAMP AT magdod ,lEH,AWARD)